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Mannheimia (Pasteurella) haemolvtica A1 is a bacterial pathogen associated with 
bovine respiratory disease (BRD) also known as shipping fever. Most bacterial pathogens 
have developed one of two iron acquisition systems, either a high affinity siderophore 
acquisition system or an outer membrane transferrin/lactoferrin receptor system. The iron 
acquisition system allows the pathogenic bacteria to obtain iron from the host's iron binding 
proteins. Pasteurella haemolvtica A1 uses the latter mechanism. When P. haemolvtica is 
grown under iron-deficient conditions, three periplasmic iron-regulated proteins (PIRPs) are 
expressed. The expressed PIRPs had molecular weights of 31, 35, and 45 kiiodalton (kDa). 
The 35-kilodalton PIRP from P. haemolvtica serovar A1 has been isolated from osmotic 
shock fluids with a two step ammonium sulfate precipitation procedure. The purified and 
characterized protein had an isoelectric pH (pi) of 6.8 and a molecular weight of 35,822. 
Equilibrium velocity ultracentrifugation established that the protein existed as a monomer 
under native conditions with a Mr of 33,795. The secondary structure revealed the protein 
contained 34.1% alpha helical structure, 16.8% p sheet, 31.1% P turns, and 17.9% random 
structure. The N-terminal sequence of the protein was ANEVNVYS YRQPYLIEPMLK. The 
35-kDa protein was identified from the N-terminal sequence as the FbpA homologue of the 
Haemophilus influenzae iron transport protein. Expression of the iron-regulated protein was 
inhibited by Fe3+ and by Fe2+, but not by Cu2+, Co2+, Ni2+, Mn2+, and Zn2+. P. haemolvtica 
up-regulated and expressed receptors for transferrin, hemoglobin, and lactoferrin to obtain 
iron, but did not produce siderophores to acquire iron. Receptors for hemoglobin and 
lactoferrin have not been described previously for P. haemolvtica Al. Most cattle had low 
vi 
antibody levels to the 35-kDa protein. Therefore, the 35-kDa FpbA would not be a good 
candidate for a serologic test for detection of antibody to P. haemolvtica. The results also 
showed that convalescent cattle had high IgG antibody levels to the 35-kDa FpbA, suggesting 
the 35-kDa protein could be a potential component for an improved vaccine. 
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INTRODUCTION 
Pasteurella haemolvtica serovar Al is a Gram-negative bacterium and a bacterial 
pathogen that is associated with bovine respiratory disease (BRD) known also as shipping 
fever (Frank, 1989). It has been estimated that the annual expenditures on BRD for 
prevention and treatment are well over $3 billion (Griffin, 1997). BRD is a multifactorial 
disease and stress factors such as shipping, confinement, and exposure to viral and 
bacterial organisms (Frank and Smith, 1983) contribute to the disease complex. The 
resulting lesions of BRD are manifested as fibrinohemorrhagic pneumonia and can be 
fatal (Frank and Smith, 1983). Pasteurella haemolvtica serovar A1 is the predominant 
isolate from cattle with pneumonia. However, P. haemolvtica can also be isolated from 
the nasal passages of healthy animals (Frank and Smith, 1983). 
Virulence factors associated with P. haemolvtica are capsular polysaccharides, 
neuraminidase, O-sialoglycoprotease, ^-lactamase, hemolysin, leukotoxin, and iron-
regulated proteins. One feature common and essential to all invasive pathogens is their 
ability to multiply in the host. In response to bacterial infection, lactoferrin is released 
from the neutrophil granules and binds iron, which results in the clearance of iron from 
the serum thus contributing to hypoferraemia (Griffiths, 1983; and Weiss et al. 1995). 
Pathogens need iron for maintenance and growth, and it is postulated that an 
organism's ability to acquire iron in vivo is an important virulence attribute (Neilands, 
1982; Ogunnariwo and Schryvers, 1990; and Weiss, et al., 1995). When environmental 
iron is a not readily available, most pathogenic bacteria up-regulate one of two iron 
acquisition systems, the siderophore up-regulation system (Neilands, 1982; and Schwynn 
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and Neilands, 1987) or the transferrin, lactoferrin, hemopexin and hemoglobin receptor 
system (Ogunnariwo and Schryvers, 1990; Ogunnariwo and Schryvers, 1992; Gray-
Owen and Schryvers, 1996; Lee and Hill 1992; Wong et al., 1995; Izadi et al., 1997; and 
Hasan et al., 1997). P. haemolvtica expresses transferrin receptors (transferrin binding 
proteins A and B, TbpA and TbpB) in response to iron limitation. These receptor proteins 
are negatively regulated by the for gene (Ogunnariwo and Schryvers, 1992). 
Although several early reports have been published on the up-regulation of P. 
haemolvtica outer membrane proteins under iron restriction (Donachie and Gilmour, 
1988; Deneer and Potter, 1989; Ogunnariwo and Schryvers, 1990; Lainson et al., 1991; 
Davies et al., 1994; Gatewood et al., 1994; Confer et al., 1995; Gray-Owen and 
Schryvers, 1996; and Mahasreshti, 1997), and the up-regulation of periplasmic proteins in 
general (Martinez et al. 1990; Lainson et al., 1991; Harkness, 1992), reports describing 
the isolation, purification, and characterization of the periplasmic proteins did not appear 
until much later (Belzer et. al., 1997; Tabatabai and Frank, 1997; and Kirby et al., 1998; 
Belzer et al., 2000). Tabatabai and Frank (1997) showed that three periplasmic proteins 
were expressed when P. haemolvtica was grown in an iron-restricted medium. They 
purified and characterized the 31-kDa periplasmic iron-regulated protein, which showed 
homology to the iron transport protein of H. influenzae described by Harkness et al. 
(1992). 
No information was previously available on the identity of the 35-kDa protein that 
was expressed P. haemolvtica under the iron-restricted conditions of the growth medium. 
Therefore, experiments were designed to improve the method for the expression, 
isolation, and purification of the 35-kDa iron-regulated protein. 
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The objectives of this research will be described in three parts. First, I will 
describe the method used for expression of the 35-kDa protein, for its purification, and 
characterization. Secondly, I will describe experiments conducted to determine the effect 
of divalent metal ions on the expression of the 35-kDa protein, to assess siderophore 
production, and to determine the expression of transferrin, lactoferrin, and hemoglobin 
receptors. Thirdly, I will describe the screening of a cosmid library and an initial attempt 
to isolate and clone the gene encoding the 35-kDa periplasmic iron-regulated protein. 
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REVIEW OF THE LITERATURE 
A Historical Review of Bovine Pasteurellosis 
The family Pasteurellaceae originally described in 1887, accommodated a large 
group of Gram-negative chemoorganotropic, facultatively anaerobic and fermentative 
bacteria and included the genus Pasteurella (Mutters et al., 1989). The earliest 
descriptions of the bacteria from the genus Pasteurella were provided by Rivolta and 
Revolee in 1879 (Mutters et al., 1989). Both Pasteur in the years 1880-81 and Kitt in 
1885 have been credited for the first isolation of the organism in pure culture (Heddleston 
etal., 1962). In 1887, Count Trevisan of Italy suggested the name of Pasteurella for the 
genus in commemoration of Louis Pasteur's work for elucidating the causative agent of 
fowl cholera in turkeys (Mutters et al., 1989). In 1921 Jones reported strains of bovine 
pasteurellae (Mutters et al., 1989). After extensive studies, Newsom and Cross (1932) 
suggested these strains be classified as separate species and proposed the name of P. 
haemolvtica. Organisms belonging to the genus Pasteurella can infect many animal 
species and cause different diseases. Pasteurella haemolvtica is considered a major factor 
in bovine respiratory disease (BRD) (Frank, 1979). The primary serovar responsible for 
clinical signs and pathophysiologic events in bovine pasteurellosis is serovar Al. A 
study describing the prevalence of P. haemolvtica serovars obtained from diagnostic 
laboratories from several upper midwestem states found that 60% were serovar Al, 26% 
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were serovar A6, and 7% were serovar A2. This study showed that P. haemolvtica 
serovars Al and A6 are most frequently associated with BRD, (Al-Ghamdi et al., 2000). 
Description of the Organism 
Pasteurellaceae are generally Gram-negative, small rods or coccobacilli, microaerophilic 
or facultatively anaerobic, non-motile and non-spore forming. P. haemolvtica grown on 
blood agar produces off-white, small, raised, opalescent colonies which are slightly 
irregular in shape with a weak zone of ^-hemolysis beneath the colony (Adlam, 1989). P. 
haemolvtica can be grown aerobically or in five percent CO2 at 37°C. 
P. haemolvtica structurally resembles other Gram-negative organisms and has, in 
addition, serotype specific capsular polysaccharides (Adlam, 1989). Although flagellae 
are absent, two types of fimbriae are present on the surface of serovar Al organisms 
when grown on solid medium. P. haemolvtica produces a potent and specific cytotoxin 
(leukotoxin), a haemolysin, and an extracellular neuraminidase. P. haemolvtica is 
oxidase positive, produces alkaline phosphatase, catabolizes glucose, reduces nitrate, 
does not produce growth on Simmons citrate medium, does not have arginine dihydrolase 
activity, and does not utilize adonitol or L-sorbose, (Krieg and Holt, 1984). 
Pasteurella organisms were typed originally by an indirect haemagglutination 
(IHA) test (Carter, 1956). In 1960, Biberstein et al. identified 12IHA serotypes isolated 
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from cattle, sheep, and goats. Nine of these serotypes fermented arabinose (biovar A), 
and 3 serotypes fermented trehalose (T) (Smith, 1961). 
Recently, the T biovars of P. haemolvtica were classified as P. trehalosi based on 
16S rRNA sequence information, protein profiles and carbohydrate profiles (Davies et 
al., 1996, Davies et al. 1997, and Sneath and Stevens, 1990). P. haemolvtica biovar A is 
differentiated on the basis of glucose fermentation, utilization of D-xylose, L-arabinose, 
and L-rhamnose. L-fructose and D-sorbitol are not used by P. haemolvtica biovar A 
(Smith, 1961). Angen et. al. (1999a; and 1999b) proposed a reclassification of the 
trehalose-negative P. haemolvtica complex (Al, A2, A5-9, Al 1-14 and A16), stating that 
these organisms should be placed in a new genus called Mannheimia. This proposed 
change is based on phenotypic data, ribotyping, multifocus enzyme electrophoresis, 16S 
rRNA sequencing and DNA-DNA, RNA-DNA hybridization (Dewhirst et al., 1993 and 
Angen et al., 1997a,b, c). In this dissertation I will refer to the organism as P. 
haemolvtica. 
Epidemiology 
Bovine respiratory disease is also known as shipping fever, stockyard fever, 
stockyard pneumonia, transient fever, hemorrhagic septicemia (now reserved for 
systemic infections with P. multocida). fibrinous pneumonia, pasteurellosis and exposure 
disease (Yates 1982). In the late nineteenth century the term "shipping fever" was first 
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used to describe diseases characterized by fever and pneumonia of cattle following 
railroad transit (Rehmtulla and Thomson, 1981). 
Bovine respiratory disease is a disease of multifactorial etiology. Stress due to 
shipping, confinement, and exposure to viral diseases contribute to the BRD complex. In 
general, the complex consists of three clinical entities including enzootic pneumonia of 
calves, shipping fever complex, and atypical interstitial pneumonia. Shipping fever is an 
entity within the BRD complex (Yates, 1982). After many years of experimental 
reproduction of pneumonic pasteurellosis and the unfailing isolation of pasteurellae from 
untreated natural cases of shipping fever, the etiology of the condition is still unclear 
(Yates, 1982). While it is true that contributing factors have been identified, the 
mechanisms whereby host, pathogens, and environment interact to cause disease are 
incompletely understood (Yates, 1982; Ames, 1997; and Glaser et al., 1999). 
In 1956 Carter serotyped 51 isolates of P. haemolvtica from cattle affected with 
shipping fever. All isolates were serologically identical, thus providing evidence that 
very few serotypes are involved in BRD (Frank, 1989). P. haemolvtica Al is the 
predominant isolate from cattle with BRD, and is isolated almost exclusively from lungs 
of cattle that die from acute BRD (Frank, 1979). 
Interestingly, P. haemolvtica serovar Al resides in the nasopharynx as a 
ubiquitous commensal in healthy animals (Dungworth, 1985). It is possible to culture the 
organism from the nasopharynx of healthy and infected cattle (Frank, 1989). However, it 
is not readily detectable by nasal swab cultures (Frank and Smith, 1983). Furthermore, 
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healthy unstressed cattle are not readily colonized with P. haemolvtica (Frank et al., 
1987). 
Calves that are up to six months of age and raised in crowded, enclosed and 
confined conditions will most likely develop enzootic pneumonia. The diagnosis of BRD 
is based on isolation of P. haemolvtica from the pneumonic lung or from nasal swabs. 
Pneumonic pasteurellosis is often fatal, develops predominantly in weaned and yearling 
cattle that have been recently transported, and is characterized by severe fibrinous 
pneumonia (Confer et al., 1988; Rehmtulla and Thomson, 1981; and Thomson et. al., 
1975). 
As stated previously, under normal conditions, P. haemolvtica Al, A6, and A2 
may be cultured from the nasopharynx of healthy animals; however, epidemiological 
studies on BRD are difficult to conduct (Bisgaard, 1993). Under stressful conditions, P. 
haemolvtica behaves as an opportunistic secondary invader (Frank et al., 1987). The 
factors that govern the ecological preference that P. haemolvtica shows for a specific 
surface and host remain unknown and the mechanism of colonization, survival, 
multiplication, invasion and pathogenic action is not completely understood (Bisgaard, 
1993). The maintenance of P. haemolvtica in animals seems to depend on persistent 
infection and shedding. The source of P. haemolvtica that causes pneumonic 
pasteurellosis in an individual calf could either be its own nasopharynx or that of another 
calf. It is the affected host's physical health, that allows multiplication of large numbers 
of P. haemolvtica. The bacterial population rapidly replicates in the nasopharynx, travels 
to the lungs, and inspired as aerosol droplets (Frank, 1986 and 1989). Any condition that 
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is stressful to the host animal or impairs its health status and promotes close contact 
between hosts will contribute to the spread of P. haemolvtica and to the development of 
pneumonic pasteurellosis. Pneumonic pasteurellosis is classically associated with severe 
physical stress (Anderson et al., 1991; Weekley et al., 1992, 1993a, 1993b; Weekley and 
Eyre, 1993; Weekley and Eyre, 1994; and Kraabel and Miller, 1997). Kraabel and Miller 
(1997) showed that chronically stressed bighorn sheep exhibited elevated Cortisol levels, 
which affects the severity of pneumonic pasteurellosis. Weekley and Erye (1994) and 
Kraabel and Miller 1997) suggest that an unknown component in the host response to 
stress, natural disease or vaccination may play a key role in the initiation and 
development of the clinical disease. 
Viruses that are also ubiquitous in cattle have been associated with BRD. The 
most frequent being parainfluenza-3 (PI-3) virus, infectious bovine rhinotracheitis virus 
(IBR) and bovine viral diarrhea virus (BVDV). These all have the capability to cause or 
contribute to severe BRD, but infections are generally mild or asymptomatic in healthy, 
unstressed cattle. The mechanism that links viral infection to P. haemolvtica pneumonia 
is not understood, although a number of possible mechanisms have been suggested. For 
example, the direct physical effect of complete or abortive viral replication can damage 
physical barriers such as the mucociliary blanket. Also, the surface structures of airways 
may be altered by viruses to permit enhanced bacterial attachment and possible 
colonization (Briggs, 1988). Constituents of mucous or alveolar fluid may be altered to 
allow more rapid bacterial replication or impeded migration of host phagocytic cells as in 
pulmonary edema. Macrophages or lymphocytes may become infected with the virus 
and undergo functional impairment or destruction (Briggs, 1988). Viruses induce fever, 
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malaise, tachypnea, elevated plasma, Cortisol and interferon production. The generated 
by-products of viral infection are reported to affect both the humoral and cell-mediated 
immunity (Roth, 1984 and Roth and Kaeberle, 1982). There is evidence that severe 
forms of BRD observed in the field result only when bacterial pneumonia is present 
(Briggs, 1988). Bacterial virulence factors are thought to be insufficient by themselves to 
enhance pulmonary colonization, but P. haemolvtica when in concert with other stressors 
cause disease (Briggs 1988). In 1992 Briggs and Frank found substantially increased 
elastase activity in nasal mucus along with slight, but significant, increase in protein 
concentration and febrile response on day 3 after IBR virus exposure and 2 days before 
marked P. haemolvtica colonization of the nasal passages. 
Management of cattle plays a major role in BRD. It is a common practice to 
gather newly weaned calves together from a number of different sources, hold them in a 
collecting area, and then transport them long distances to feed yards. Cattle that become 
ill from viruses because of herding are highly susceptible to pneumonic pasteurellosis. 
Therefore, the current methods for marketing and raising cattle contribute to the 
incidence and severity of the BRD (Frank, 1989). 
Pathogenesis and Virulence Factors 
Pasteurella haemolvtica has been shown to have several virulence factors (Confer 
et al. 1990). Factors that have been cited are fimbriae, lipopolysaccharide, leukotoxin, 
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capsular polysaccharide, neuraminidase, protease, haemolysin, ^-lactamase and iron-
regulated proteins. 
Fimbriae 
Many Gram-negative bacteria posses filamentous protein structures on their 
surface called fimbriae. In 1987 and 1988, Morck et. al. observed fimbriae on the 
surface of P. haemolvtica isolated from an infected calf. Fimbriae are thought to be 
responsible for specific adherence to cell surfaces in the initiation of infection. 
According to Morck et. al. (1988), although the isolated P. haemolvtica contained 
fimbriae, antibodies to fimbriae were not observed. 
Lipopolvsaccharides 
Lipopolysaccharide (LPS) or endotoxin is an important virulence factor involved 
in several complex virulence mechanisms (Whitely et. al. 1990; Whitely 
et. al. 1991; and Whitely et. si. 1992). These authors reported that purified P. 
haemolvtica LPS administered intrabronchially caused pulmonary edema, platelet 
aggregation, neutrophil accumulation, and fibrin exudation. Furthermore, they observed 
that LPS stimulates neutrophils (Paulsen et al., 1990), and macrophages to produce 
proinflammatory cytokines (Cohly et al., 2001; Lafleur et al., 2001; Husan et al., 1999; 
and Whitely et. al. 1991). The cytokines released during macrophage activation include 
tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8. These activated 
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macrophage cytokines play a central role in the lung injury associated with a P. 
haemolvtica infection (Cohly et al., 2001 ; Lafleur et al., 2001 ; Husan et al., 1999). 
Leukotoxin 
Benson et al. (1978), Markham et al. (1982), Wilkie et al. (1990), and Majury and 
Shewen (1991a,b) showed that P. haemolvtica culture supernatants or washed P. 
haemolvtica cells were toxic for bovine alveolar macrophages. This cytotoxin 
(leukotoxin) is specific for alveolar macrophages, circulating blood lymphocytes, 
neutrophils and cultured blood mononuclear cells from cattle, sheep and goats, but is not 
cytotoxic for cells from swine, horses or humans (Adlam, 1989, and Gerbig et al., 1992). 
Leukotoxin (LKT), a pore-forming cytolysin, is a protein with a molecular weight of 
about 120 kDa, and is involved in aggregation of neutrophils (Conlon et al., 1992), and is 
a ruminant-specific pore-forming cytolysin (Shewen and Wilkie, 1982; Cruz et al., 1990; 
Highlander et al., 1990; Gerbig, et al., 1992; Stevens and Czuprynski, 1996; Kraabel and 
Miller 1997; Hsuan et al., 1999; and Sun et al., 1999). In 1998, Tatum et al. constructed 
an isogenic leukotoxin deletion mutant (IktA) of P. haemolvtica Al. They found that 
when comparing the mutant to the parent, there was a significant reduction in virulence in 
the IktA mutant as measured by clinical and lung lesion scores. Lastly, iron is required 
for the production of leukotoxin (Gentry et. al. 1986; and Cudd et al., 1999). These 
authors also reported that an influx of extracellular Ca2+ is necessary to produce 
leukotoxin-induced neutophil responses of membrane perturbation and lysis. 
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Capsular polysaccharide 
Capsular polysaccharide (CP) may be involved in bacterial adherence to the 
mucosa of the lower lung, resistance to complement-mediated lysis, and inhibition of 
phagocytosis by neutrophils (Morck et al. 1991). Confer et al. (1989) and McVey et al. 
(1990) reported that purified CP could induce an antibody response. They stated that the 
antibody response to purified CP correlates with protection from challenge with virulent 
P. haemolvtica. 
Neuraminidase 
The production of neuraminidase by P. haemolvtica was demonstrated first by 
Scharmann et al. (1970), neuraminidase activity of P. haemolvtica isolates was reported 
by Frank and Tabatabai (1981), and characterized by Tabatabai and Frank (1981). 
Neuraminidase catalyzes the hydrolysis of the glycosidic linkage of a terminal sialic acid 
residue linked to a D-galactose or a D-galactosamine residue. This enzyme is present in 
several viral and bacterial pathogens. It has been suggested that neuramidase caused a 
reduction in the protective function of the epithelial mucous rendering it less able to 
entrap and remove invading microorganisms (Adlam, 1989). Straus, and Purdy (1995) 
found that neuraminidase production is required for P. haemolvtica to cause pneumonic 
infections in cattle regardless of its serotype. In 1998, Straus et al. reported on the 
characterization of neuraminidase production by P. haemolvtica and showed that all 12 
serotypes (including four P. trehalose serotypes) produced an immunologically similar 
form of the enzyme. 
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Proteases 
Proteases also are believed to play a role in pathogenesis. Abdullah (1990) 
reported that P. haemolvtica produced O-sialoglycoprotease activity in most serotypes. 
Glycoprotease is specific for O-linked sialoglycoproteins; it does not cleave N-linked 
sialoglycoproteins or de-sialated substrates (Watt et al., 1997). The protease was 
cytotoxic for bovine pulmonary macrophages. Evidence is mounting that suggested that 
growth and proliferation of pathogenic bacteria depended on proteolytic enzymes of the 
invading organism as well as those of the host (Travis et al., 1995). Lee and Shewen 
(1996) found that P. haemolvtica Al produced an IgGi-specific protease and suggested it 
may be a virulence mechanism contributing to the pathogenesis of BRD. 
Tabatabai (1995) determined the specificity of the cleavage sites of the O-
sialoglycoprotease using bovine fetuin as a substrate. Three main cleavage sites were 
found, between serine272 and valine273, leucine286 and histidine287, and lysine49 and 
valine50. 
Hemolysin 
Very little information is available in the literature on the hemolysin of P. 
haemolvtica (Adlam, 1989). Hemolysin causes the lysis of red blood cells and liberation 
of hemoglobin. However, it is suggested by Strathdee and Lo (1987), and Adlam (1989) 
that leukotoxin and hemolysin might be the same protein. 
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B-lactamase 
Livrelli et al. (1991) found a gene that encoded the enzyme ^-lactamase. Then 
Rossmanith et al. (1991) reported that P. haemolvtica had both plasmid-negative and 
plasmid-positive strains that showed multiple drug resistance. The ^-lactamase enzyme 
destroys the activity of certain ^-lactam antibiotics by hydrolyzing the p-lactam bond in 
the molecule. This antibiotic resistance contributes to the organism's pathogenesis. 
Vaccines for Pneumonic Pasteurellosis 
Many studies have been conducted on the immune response in cattle to 
Pasteurella in an effort to gain insight on both natural and experimental infection. 
Stevens et al. (1997b) reported at least 70% of dairy calves had serum antibody titers to 
P. haemolvtica at 1 to 14 days of age. It is not unreasonable to deduce from this finding 
that there was a natural exposure to the Pasteurella organism. The immune response in 
cattle depended on the history of exposure of the calf to the organism. The route of 
exposure and the severity of exposure influenced all aspects of the immune response 
(Frank, 1989). 
Resistance to the natural disease of Pasteurella has been correlated with the 
presence of naturally occurring antibody to P. haemolvtica Al (Frank, 1989). Thomson 
(1981) stated that feedlot cattle that had lowered serum antibody titers to P. haemolvtica 
were prone to become ill with BRD. Antibody titers to P. haemolvtica in serum, 
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pericardial fluid or peritoneal fluid collected from feedlot cattle that died of fibrinous 
pneumonia was lower than those of cattle that died from other causes. High serum 
antibody titers in cattle correlated with resistance to an experimental transthoracic 
challenge (Confer et al., 1986; and Confer et al., 1988). Recovery from BRD caused by 
the experimental challenge of P. haemolvtica provided protection against subsequent 
challenge. Calves that recovered from experimental aerosol exposure to a combination of 
a specific virus and P. haemolvtica were resistant to an experimental aerosol exposure of 
P. haemolvtica (Jericho et al., 1986). Cattle exposed to an aerosol of live P. haemolvtica 
infection developed serum antibody titers that correlated directly with resistance. 
Although calves exposed via the respiratory tract have both serum and local antibody to 
P. haemolvtica. and may be resistant to P. haemolvtica challenge exposure, the antibody 
may not be protective against the bacterium during a severe viral respiratory disease 
(Frank, 1989). 
Vaccine development for prevention of BRD in the feedlot remains an issue for 
the livestock industries. Several vaccine formulations have been tried over the years, 
including antisera to whole P. haemolvtica. inactivated bacteria, P. haemolvtica extracts, 
toxoid, subunit, modified live cells, tissue-culture derived cells, and live preparations in 
both experimental and commercial vaccines (Kucera et al., 1983; Lessley et al., 1985; 
Loan and Purdy, 1986; Blanchard-Channell et al., 1987; Loan and Tigges, 1989; Mosier 
et al., 1989a; Austin et al., 1992; Weekley and Eyre, 1993; Mosier et al., 1994; Conlon et 
al., 1995; Houghton, 1995; Mosier et al., 1995; Bechtol and Jones, 1996; Sreevatsan et 
al., 1996; Srinand et al., 1996; Stevens et al., 1997a; Stevens et al., 1997b; Confer et al., 
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1998; Mosier et al., 1998; Potter et al., 1999; Gummow and Mapham, 2000; and Hodgins 
and Shewen, 2000). 
Live Vaccines 
Confer et al. (1985) used a live P. haemolvtica vaccine administered by aerosol, 
intradermal or by the subcutaneous route. These investigators observed a significant 
reduction of lesions after transthoracic challenge exposure. Live P. haemolvtica vaccines 
have been demonstrated to have a dose effect when administered intradermally (Confer, 
1985). Blanchard-Channell et al. (1987) designed a streptomycin-dependent live P. 
haemolvtica vaccine and found that serum antibody titers against P. haemolvtica 
fluctuated among animals in all groups. In comparing antibody titers and severity of 
illness they did not observe a significant correlation between the two parameters. Stevens 
et al. (1997a) reported that immunization with live P. haemolvtica caused the formation 
of antibodies to cell surface antigens and leukotoxin which protected against pneumonia. 
According to Mosier et al. (1998) live vaccines are the most consistently effective. This 
is thought to be due, in part, to the production of virulence factors such as endotoxin or 
lipopolysaccharide (LPS) and leukotoxin, and inflammatory mediators (IL-1, TNF, 
platelet activating factor, prostacyclin, prostaglandin, tissue factor, and plasminogen 
activator factor) under in vivo conditions (Whiteley et al., 1992 and Mosier et al., 1998). 
In field conditions, the administration of live vaccines may sometimes fail due to 
the concurrent administration of antibiotics or due to the storage, administration, or 
improper handling of the live vaccine. 
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Commercial vaccines 
Commercial vaccines are available, consisting of both live and killed components. 
Due to husbandry practices and field conditions, the commercial vaccines efficacy has 
been variable, and has resulted in either disease severity increase, or poor protection 
(Confer et al. 1985, Confer et al., 1988, and Wilkie et al., 1990). Recently, five 
commercial vaccines (Leuko Tox M, Leuko Tox 1, Presponse HM, One shot, and Once 
PM-H) were studied in calves for duration of immunity after vaccination. Following 
vaccination with these five vaccines (representing killed and cellular components) Loan 
et al. (1997) found that the antibody titers did not correlate well with deaths and lung 
lesions. The results showed marked differences in duration of immunity indicating that 
other immune mechanisms may also be important. 
Pasteurella haemolvtica commercial bacterins have been studied exhaustively. 
There is evidence that these commercial bacterins may stimulate an adverse reaction 
(Stevens et al., 1997b). Stevens et al. (1997b) further suggested that bacterins containing 
whole killed P. haemolvtica without leukotoxin induced formation of opsonizing 
antibodies that enhanced contact between phagocytes and the organism. Without 
concurrent stimulation of antileukotoxin antibody production there was more contact 
between P. haemolvtica and the phagocytes. This caused an increase in the production of 
cytokines during the contact phase, which stimulated phagocyte cell lysis and resulted in 
an increase of lung damage (Stevens et al. 1997b). 
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Non-viable vaccines 
Non-viable bacterial vaccines include inactivated and killed attenuated bacterial 
preparations. Confer et al. (1988) stated that bacterins when given at the same dosage as 
live bacterial vaccines failed to confer resistance to BRD as would be expected. 
Bacterins may have a wide range of action, including adverse reactions to the host, 
conferring minimal protective responses, or conferring positive protective responses 
(Mosier et al., 1998). Confer et al. (1988) suggested that successful vaccination 
depended on the site of injection, the dose of the vaccine and the age of the host. This 
may explain the inconsistent host response and resistance to disease with the non-viable 
bacterial preparations. 
The currently available Pasteurella vaccines are formulated to stimulate immunity 
by either providing an adequate antigenic mass in the administered dose, or by 
relying on subsequent production of antigens by in vivo growth of live organisms. The 
ability of these different types of vaccines to stimulate rapid and high titers to key 
antigens is a key factor that will influence subsequent resistance to disease (Weekley and 
Eyre, 1994 and Mosier et al., 1998). 
Protective Antigens 
There are several antigens of P. haemolvtica that have been demonstrated to 
correlate with protection. Gentry et al. (1985) showed that leukotoxin neutralization 
titers correlated well with protection against challenge by aerosol exposure. Confer et al. 
(1985) found antibody to fractions of saline extracts of P. haemolvtica that contained 
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concentrated amounts of carbohydrates correlated with resistance to transthoracic 
challenge, whereas antibody to whole extract did not. Cattle with high serum antibody 
titers to lipopolysaccharide (LPS) were not resistant to challenge exposure (Confer et al., 
1988 and Mosier et al., 1989a). They reported that antibody to a 31 kDa, a 49 kDa and a 
86 kDa surface protein were important in resistance to challenge exposure (Mosier et al., 
1989b). Nelson and Frank (1989) isolated a 94-kDa antigen from P. haemolvtica 
serotype A1. Antibody to this antigen was found in nasal secretions and sera of cattle 
exposed to P. haemolvtica. 
In 1991, Gilmour et al. reported enhanced protection in lambs against 
pasteurellosis when given a vaccine containing iron-regulated proteins of P. haemolvtica 
A2. Western blots using sera from immunized animals showed that sheep immunized 
with iron-regulated proteins had a strong antibody response to iron-regulated outer 
membrane proteins with molecular weights of35,000 70,000 and 100,000. Then in 1991, 
Lainson et al. described a 35-kDa iron-regulated periplasmic protein in P. haemolvtica 
A2 that was immunogenic in mice. Whether or not this protein conferred protection was 
not discussed. 
Belzer et al. (1996, 1997) identified a periplasmic iron-regulated protein (PIRP) 
with a molecular weight of 35,000 that was strongly immunoreactive with serum from 
convalescent cattle and weakly immunoreactive with serum from infected cattle. 
However, no information is available whether the 31 and 35 kDa proteins could serve as 
protective antigens in cattle. Except for the report by Lainson et al. (1991), no 
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information has been published on the ability of the periplasmic proteins to serve as 
protective antigens. 
In 1999, Potter et al. reported that the transferrin receptor, TbpB, of P. 
haemolvtica. contributed to protection in cattle. Recombinant TbpA and TbpB proteins 
from P. haemolvtica A1 were tested for their ability to confer protection against 
experimental infection when administered to calves in vaccine formulations containing 
one or both antigens (Potter et al., 1999). The calves that received TbpB alone had high 
antibody titers against the antigen at the time of challenge. However, those with TbpA 
alone did not have an antibody response. Potter et al. (1999) also reported that the group 
that had both TbpA and TbpB showed the best protection when challenged with the 
experimental P. haemolvtica organism. The data also showed that the amount of 
protection directly correlated with the amount of anti-TbpB antibody. Potter et al. (1999) 
hypothesized that because the combination of TbpA and TbpB had the greatest 
protection, TbpA must contribute to protection through the induction of a non-antibody-
mediated immune response. These authors further reported that recombinant anti-serovar 
A1 TbpB was cross-reactive with TbpBs of other P. haemolvtica serovars. 
Current Diagnostic Techniques 
Colony appearance on blood agar, (^-hemolysis of P. haemolvtica and rapid plate 
agglutination, can be used to identify P. haemolvtica. The formation of a narrow zone of 
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hemolysis on 7% ovine or bovine blood agar, and growth appearing as small gray 
colonies are used to distinguish P. haemolvtica from other Pasteurella species (Adlam, 
1989), as is the organism's ability to grow on MacConkey agar, their lack of urease or 
indole production, and their ability to ferment arabinose but not trehalose. The majority 
of biotype A ferment arabinose, but not trehalose. All biotype T isolates ferment 
trehalose (Adlam, 1989). P. haemolvtica can additionally be differentiated from P. 
multocida by its ability to ferment maltose, dextrin and inositol (Adlam, 1989). 
Biberstein et al. (1960) was the first to establish serotypes of P. haemolvtica by 
using the indirect hemagglutination assay (IHA). This test relied on the differences 
between capsular polysaccharides. In 1978 (Frank and Wessman) developed a rapid 
plate agglutination method using serotype-specific antisera to P. haemolvtica prepared in 
rabbits. In order to gain a better understanding of the molecular mechanisms involved in 
the pathogenesis of P. haemolvtica. basic research on the identification of virulence 
factors should allow the development of improved commercial vaccines and diagnostic 
tests for P. haemolvtica. 
Iron Acquisition by P. haemolvtica 
During infection the host sequesters iron which leads to hypoferremia. 
Hypoferremia in turn, provides an important line of defense against pathogenic 
microorganisms (Weinberg, 1984; Griffiths and Williams, 1999; Luke and Campagnari, 
1999). Most of the iron present in the body is intracellular in the ferrous form (Fe-II) in 
hemoglobin, heme, ferritin, or hemosiderin, and extracellular iron (Fe-Œ) is complexed 
to the high-affinity iron-binding glycoproteins transferrin and lactoferrin (Luke and 
Campagnari, 1999). 
When microorganisms are in an iron-restricted environment (such as in lung 
tissue), they express iron-regulated outer membrane proteins (Donachie and Gilmore, 
1988; Deneer and Potter, 1989; Ogunnariwo and Schryvers, 1990; Lainson et al. 1991; 
Davies et al., 1994; Gatewood et al. 1994; and Confer et al. 1995). These outer 
membrane proteins bind host iron-bound proteins and subsequently allow transport of 
iron into the bacterial cell. Convalescent calves recovering from P. haemolvtica infection 
had antibodies to these outer membrane iron-regulated proteins (Confer et al., 1985; 
Deneer and Potter, 1989; Donachie and Gilmore, 1988; and Confer et al., 1995. 
Iron may be important in pneumonic pasteurellosis because bacteria compete with 
host tissues for bound and free iron, and increased availability of free iron increases the 
pathogenicity of bacterial infections (Slocombe et al., 1990). Since iron plays a central 
role in bacterial infections, it influences both bacterial virulence and host cellular defense 
mechanisms. Because iron is a critical element essential for the growth of many 
organisms, this requirement for iron suggests that this function is an important 
component of colonization and infection (Gray-Owen and Schryvers, 1996; and Braun, 
1997). Iron serves as a cofactor in a variety of critical enzyme reactions including the 
respiratory electron transport components (cytochromes, sulfite reductase) and iron 
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storage proteins (ferridoxin), in the decomposition (catalase) and utilization (peroxidase) 
of hydrogen peroxide, and, together with other metal ions, in the dismutation of 
superoxide anion (superoxide dismutase). Iron is utilized as a cofactor in nitrogen-
fixation by nitrogenase of Rhizobium spp. (Leong, 1980). Finally, iron is required by 
ribonucleotide reductase, for the synthesis of deoxyribotides for DNA biosynthesis, and 
serves as an environmental cue to trigger virulence factor expression through the 
generation of reactive oxygen species (Kirby et al., 1995; Gray- Owen and Schryvers, 
1996; Braun and Killmann, 1999; and Ratledge and Dover, 2000). 
To survive in and colonize the animal host, many mammalian pathogens have 
evolved several mechanisms that allow them to obtain iron in vivo. Both iron-binding 
compounds and specific receptors for iron carrier proteins have been described for many 
of these bacteria (Luke and Campagnari, 1999). Microbes have developed an array of 
iron-acquisition processes that are activated in low iron environments, and when active 
infections occur, a contest ensues for iron. Pathogenic bacteria utilize multiple iron-
acquisition systems including (but not limited to) those that have siderophore-based ferric 
uptake mechanism, those with systems that bind transferrin or lactoferrin receptor 
proteins, and those that bind the heme-hemopexin complex (Wong et al., 1994; Gray-
Owen and Schryvers, 1996; Hasan et al., 1997; Izadi et al., 1997; Padmamalini et al., 
1998; Byers and Arceneaux, 1998; and Bullen et. al., 2000). Transferrin-bound iron is 
found predominately in serum, while it is thought that lactoferrin is the primary carrier of 
iron on most mucosal surfaces. 
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Sideroohores 
A wide variety of microbes acquire iron through a high affinity iron uptake 
system that depends on the synthesis and secretion of low-molecular-mass iron chelators 
called siderophores. Siderophores remove iron from iron-containing proteins of 
eukaryotic hosts or solubilize it from precipitates of ferric oxyhydroxide, rendering the 
metal available for microbial uptake (Thulasiraman, et al., 1998). The iron-siderophore 
complex is transported to an outer membrane Ton B-dependent receptor, which transports 
the iron-siderophore complex into the periplasmic space (Rankin et al., 1994; and Saken, 
et al. 2000). There are two main types of siderophores, the catechol types such as 
enterobactin (enterochelin) or aerobactin (produced by Aerobactor). or the hydroxamate 
compounds (ferrichromes) as produced by Escherichia coli and Bacillus subtilis. These 
compounds are characterized by their high affinity (KA is 1047 to 1048 M"1) for ferric iron 
(Bullen et al., 2000). 
Iron-reeulated outer membrane proteins 
Pasteurella haemolvtica is not known to produce siderophores as a means to 
acquire iron, however, P. haemolvtica does express specific iron-regulated outer 
membrane proteins originally called IROMPs (Donachie and Gilmour, 1988; Deneer and 
Potter, 1989; Ogunnariwo and Schryvers, 1990; Gilmour et al. 1990; Lainson et al. 1991; 
Davies et al., 1994; Gatewood et al. 1994; and Confer et al. 1995). Recently these 
proteins have been referred to as transferrin binding proteins A and B (TbpA and TbpB). 
P. haemolvtica also expresses periplasmic iron-regulated proteins (PIRPs), (Lainson et. 
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al. 1991, and Tabatabai and Frank, 1997), now referred to as ferric iron binding proteins 
A and B or FbpA and FbpB, respectively. 
The role of iron-regulated proteins in pathogenesis has been elucidated during the 
last decade. The earliest studies investigating iron acquisition properties of disease and 
non-disease isolates of P. haemolvtica were done by Morck et al. (1991). Utilizing iron-
depleted conditions in vivo. Morck et al. was able to express several outer membrane 
proteins with molecular weights of 71, 77 and 100 kDa. Using identical growth 
conditions for P. haemolvtica biotype A strains and biotype T strains, Murray et al., 
(1992) demonstrated that iron limitation resulted in increased synthesis of outer 
membrane proteins with molecular weights of 35 kDa and 70 kDa, and 37 kDa and 78 
kDa, respectively. 
Studies were undertaken to grow P. haemolvtica under iron-rich and iron-poor 
conditions by Davies et al. (1992); these authors showed the expression of outer 
membrane protein profiles with molecular weights of 71, 77, and 100 kDa. These 
authors showed that growing P. haemolvtica in the presence of iron sequestering agents 
increased the expression of a 40.5 kDa protein, a 71 kDa and a 100 kDa protein only in 
the disease-associated strains. They also reported that bovine transferrin-supplemented 
medium resulted in increased expression of the 40.5 kDa protein and the 71 kDa protein 
but the 100 kDa protein was only slightly up-regulated in both the disease and non-
disease strains, with no observed expression of the 77 kDa protein. Transferrin-
supplemented medium also increased the expression of two new outer membrane proteins 
with molecular weights of 23 kDa and 26 kDa. The transferrin receptor of P. 
haemolvtica is reported to be specific for bovine transferrin (Ogunnariwo and Schryvers, 
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1990, and Schryvers and Gonzalez, 1990). Using affinity chromatography with 
immobilized bovine transferrin, Schryvers' group purified the transferrin-binding protein 
A and B, (TbpA and TbpB), with molecular weights of 100 kDa and 75 kDa, 
respectively. TbpA and TbpB function as receptors for transferrin (Ogunnariwo and 
Schryvers, 1990; and Gray-Owen and Schryvers, 1996). 
Iron-regulated periplasmic proteins 
The periplasmic iron-regulated proteins (Lainson et al., 1991; Harkness et al., 
1992; Tabatabai and Frank, 1997; and Tabatabai and Frank, 1999) function as iron 
binding or iron transport proteins (Gray-Owen and Schryvers, 1996; Burns et al. 1997; 
and Kirby et al. 1998) and have molecular weights ranging from 31 to 35 kDa. 
In 1991 Lainson et al. reported on the expression of a periplasmic 35-kDa protein 
in P. haemolvtica serovar A-2 when grown under iron-restricted conditions. In 1996, 
Belzer et al. described the expression of a 35 kDa in P. haemolvtica serovar A-l when 
grown in iron-depleted media. Then in 1998 (Kirby et al.) reported that the 35 kDa 
protein was a functional homologue of the ferric binding protein A (FbpA) identified in 
H. influenzae. 
Studies using purified native P. haemolvtica A1 FbpA (35-kDa) showed that 
convalescent calves had high antibody titers to the FbpA protein (Belzer et al. 1996), and 
that the native FbpA did not cross-react with other P. haemolvtica serovars (Tabatabai 
and Frank 1997). 
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Mechanism of iron acquisition 
Iron acquisition is negatively regulated by the fur gene encoding the ferric uptake 
regulation (Fur) repressor protein, and positively regulated by the tbpR gene encoding the 
TbpR protein (Gray-Owen and Schryvers, 1996). When iron is available in the bacteria, 
the Fur protein forms a complex with Fe(H). Once the Fur-Fe(II) complex is formed, the 
complex binds to the Fur box thereby blocking transcription of the functional genes 
(Ratledge and Dover, 2000). The DNA-binding motif of the Fur protein occurs in the N-
terminal domain of the protein. The Fur box itself consists of a DNA sequence that is a 
19-bp degenerate palindrome that is rich in A-T bases (Ratledge and Dover, 2000). Fur 
boxes are present on the iron-regulated tbpA. fbpABC. and exbBDtonB opérons. 
In low iron conditions, the Fur-Fe(H) complex is not formed, but the Fur protein 
binds to its positive regulator, TbpR. It has been hypothesized that the Fur-TbpR 
complex binds to the promoter upstream of the tbpA operon, inducing transcription by 
RNA polymerase, which then results in expression of the transferrin receptor proteins 
(Gray-Owen and Schryvers, 1996; Ratledge and Dover, 2000). 
Thus under low iron conditions, transferrin is up-regulated, binds iron, and the 
iron is transported through the outer membrane by an unknown mechanism. Although no 
published reports are available in the literature, Tabatabai (1998) has described an 
NADH-dependent membrane-bound ferric reductase that is capable of releasing iron 
from transferrin (unpublished results). Once the iron is released into the periplasm by 
passing through a hydrophyllic channel within TbpA, iron will bind to the FbpA. The 
FbpA then interacts with its cognate permease protein FbpB at the cytoplasmic 
membrane and transports the iron molecule into the cytoplasm. ATPase activity of FbpC 
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is required for the movement of iron through the inner membrane to the cytoplasm (Gray-
Owen and Schryvers, 1996). Once iron is in the cytosol the Fur protein-iron complex 
binds to the promoter and the transcription of functional genes ceases. When the 
condition of iron limitation again occurs, the cycle comes full circle. The Fur protein will 
bind TbpR, and then to the promoter for the start of transcription. 
During the last 10 years the role of transferrin receptors in Pasteurella and the role 
of periplasmic iron-regulated proteins (or transport proteins) in iron homeostasis are 
better understood (Schryvers, 1989; and Gray-Owen and Schryvers, 1996). However, 
little information is available on the expression and characterization of the native 
periplasmic iron-regulated proteins of Pasteurella. Isolation and characterization of iron-
regulated proteins from Pasteurella are important for understanding the potential role they 
may play in microbial virulence and iron assimilation. 
The overall objectives of the proposed project are to isolate, purify and 
characterize the 35-kDa periplasmic iron-regulated protein; to determine the role and 
occurrence of the 35-kDa protein in the P. haemolvtica serotypes; and to determine the 
immunoreactivity of the 35-kDa protein. This information may be useful for the design 
of a potential vaccine component for bovine pasteurellosis and a complimentary 
diagnostic antigen. 
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MATERIALS and METHODS 
Organism and Culture 
P. haemolvtica serovar A1 (isolate L101) was isolated from an infected bovine 
lung as described by Frank and Smith, (1983). The culture was incubated at 37°C for 20 
to 24 h with shaking until an Aéoonm of 0.5 to 1.0 was reached. For some experiments the 
medium contained 30 |iM of Fe3+ (supplied as FeCb) or 50 pM 2,2-dipyridyl to chelate 
free iron. In other experiments, the medium contained 30 fiM of Fe2+, Cu2+, Co2+, Ni2+, 
Mn2+, or Zn2+. Ca2+ and Mg2+ were not tested because these divalent metal ions were 
present in the basal medium at a concentration of 2.5 and 4.1 mM respectively. All 
media utilized for these experiments was RPMI-1640 (Gibco-BRL, Grand Island, NY) as 
both liquid and solid medium with the addition of 15 g of agar per liter. 
The medium was buffered with either (N- [2-hydroxyethyl] piperazine-N'- [2-
ethanesulfonic acid]), (HEPES), (Sigma, St. Louis, MO) pH 7.2 or sodium bicarbonate 
pH 7.2. When the medium was buffered with sodium bicarbonate, the cultures were 
incubated at 37°C with 5 % CO% for 20 to 24 h with shaking. 
Isolation and Purification of Periplasmic Protein Fraction 
The 20-h culture was centrifuged at 10,000 x g at 5°C. The cell pellet was treated 
by one of two methods. First, the cells were resuspended in 1 M NaCl-0.1 M sodium 
citrate, pH 7.8 (extraction buffer) at 0.2 g wet weight cells/ml and stirred overnight at 
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5°C (Tabatabai et al., 1979; Tabatabai and Deyoe, 1983; as modified by Belzer et al., 
1991). The cells were centrifuged and the pellet was resuspended in 20 mM HEPES pH 
7.2 using 2 ml/gm of wet weight cells. The cell suspension was frozen at -20°C. 
The periplasmic proteins were extracted from the cells by one freeze-thaw cycle. 
Thawed cells in the 20 mM HEPES pH 7.2 (2 ml/gm of wet weight cells) were stirred 20 
hours at 37°C. The supernatant was collected and cells were again resuspended in 20 
mM HEPES pH 7.2 using 2 ml/gm of wet weight cells and frozen. The extracted proteins 
were precipitated by a two-step ammonium sulfate precipitation at 50% saturation, 
followed by precipitation at 80% saturation. 
The precipitate was dissolved in and dialyzed against 5 mM NH4HCO3, followed 
by dialysis against 20 mM [2-(N-morpholino) ethanesulfonic acid] (MES), pH 5.5. Ten 
mg of protein was loaded onto a 10-ml CM-Sepharose column equilibrated in the same 
buffer. The protein was eiuted with a 100-ml linear gradient from 0 to 0.5 M NaCl in 20 
mM MES buffer pH 5.5 and absorbance was monitored at 280 nm. Fractions containing 
the 35-kDa protein were pooled, dialyzed against 5 mM NH4HCO3 and stored frozen at 
-20°C. 
For some experiments, cells were frozen, thawed, and incubated at 37°C for three 
consecutive cycles. Thawed cells were cultured on blood agar to check for viability. 
Each cycle exhibited viable P. haemolvtica. Proteins were isolated after each cycle as 
described above. 
For comparison of expressed iron-regulated proteins, cells were pelleted, and the 
periplasmic proteins were isolated by a modification of an osmotic shock procedure 
described by Berish et al. (1992). The cell culture density was measured on a Beckman 
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DU 640 and adjusted to an absorbance of 1 at 600 nm. The culture was centrifuged at 
14,000 x g, and the cell pellet was resuspended in 140 pi of 10 mM Tris, pH 7.6, 
containing 20% (w/v) of sucrose. Eight pi of 0.5 M EDTA was added to the suspension, 
mixed, and the suspension was incubated on ice for 5 min and centrifuged for 3 min at 
14,000 x g. The supernatant was removed and the cell pellet was resuspended in 140 pi 
of cold deionized water, incubated on ice for 1 h and centrifuged again (14,000 x g). The 
supernatant containing the periplasmic proteins was removed and 20 pi aliquots were 
subjected to SDS-PAGE, western blotting, N-terminal sequencing, and amino acid 
analysis. 
Isoelectric Focusing 
One microliter samples and one microliter of standard proteins of known pi 
(Sigma, St. Louis, MO) were loaded onto an isoelectric focusing (ŒF) Phastgel (pH 3.5-
9 and 4-6.5, Pharmacia Biotech). Electrophoresis, staining, and destaining were those 
recommended by the manufacturer. The pi was determined from a plot of mobility 
versus pH of the protein standard markers. 
Gel Electrophoresis and Blotting 
The fractions were denatured and submitted to electrophoresis, using 1-mm thick 
gels, 12.5% acrylamide with a 4% acrylamide stacking gel (Laemmli, 1970). Native 
PAGE was done using 7.5% homogeneous gels (Phastgels, Pharmacia Biotech) as 
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described in the protocol by the manufacturer. In all gels the protein concentration was 6 
pg/well for staining and 3 pg/well when used for blotting. 
Western blotting was done on nitrocellulose as described by Towbin et al. (1979) 
and onto polyvinylidene difluoride (PVDF) membrane (Immobilion-P, Millipore, and 
Bedford, MA) following the manufacturer's protocol. The proteins were transferred 
electrophoretically at 0.11 Amp, and 30 Volt, for 16 h at room temperature using a 
Biorad Transblot apparatus. 
Protein concentrations were determined using the Folin phenol reagent (Lowry et 
al., 1951) using bovine serum albumin as a standard. 
Mass Spectrometry 
Samples for matrix-assisted laser desorption/ionization time-of-flight (MALDI-
TOF) mass spectrometry was prepared by mixing equal volumes (0.5 pi) of protein 
sample (0.25 mg protein/ml) and saturated sinapinic acid in 50% acetonitrile-0.1% 
trifloroacetic acid. The mixture was allowed to dry on the sample strip at ambient 
temperature. 
A volume of 0.5 pi of 10% formic acid was added and allowed to dry at ambient 
temperature. The mass spectrum was obtained using a Lasermat 2000 (Finnigan) at 50% 
laser power. The spectrum was an average of 5 shots. The spectrum smoothing (= 10) 
function was applied. Bovine serum albumin (Mr = 66,000) was used as an external 
standard. 
Electro-spray mass spectrometry (ES-MS) was performed on desalted protein 
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using Bio-Gel P-6 DG (Bio-Rad), concentrated to 1 mg/ml and resuspended with an 
equal volume of 50% (v/v) methanol: deionized water that contained 1% v/v acetic acid. 
A sample amount of 100 pi was injected. The mass spectrum was obtained using a 
Finnegan MAT TSQ 700 mass spectrometer (Analytical Services, Chemistry 
Department, Iowa State University). 
N-terminal Sequencing and Amino Acid Analysis 
The stained and destained protein bands on PVDF membrane were excised, 
washed extensively with deionized water to remove residual glycine and dried between 
Whatman No. 1 filter papers and stored at -20°C. The N-terminal sequence was 
determined with an Applied Biosystems Model 477A protein sequencer. Protein bands 
from two lanes on PVDF, containing the equivalent of lpg of blotted protein per band, 
were used for sequencing. Two additional protein bands on PVDF, containing lpg of 
blotted protein per band, were excised for amino acid analysis. Bands were hydrolyzed 
with 6 N HC1 in the gas phase for 65 min at 150°C using a Picotag work station (Waters), 
following the manufacturer's protocol. 
The amino acid composition was determined using an Applied Biosystems Model 
420A (Foster City, CA) amino acid analyzer (Protein Facility, Iowa State University). 
Homology search was done using the blastp search program of the National Center for 
Biotechnology (Entrez) (Altschul et al., 1990). 
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Analytical Ultracentrifugation 
Equilibrium velocity centrifugation experiments were done to determine the 
molecular weight of the protein in its native state. Equilibrium velocity runs were done at 
three concentrations, 0.2,0.3, and 0.4 mg/ml in 20 mM MES buffer pH 5.5, 0.2 M NaCl, 
using the Beckman XL-A Maxima Optima fitted with a monochrometer. A speed of 
20,000 rpm was used. Beckman XL-A software was used to analyze the data. 
Circular Dichroism 
The sample was dissolved in 10 mM HEPES pH 7.2,100 mM KCL at a 
concentration of 0.35 mg/ml. The spectra were obtained using a Jasco J-710 
spectropolarimeter (Jasco Corporation, Tokyo, Japan). The buffer spectrum was 
subtracted from the protein spectrum. The wavelength scan was from 200 to 260 nm 
using a 0.1 cm cell. The bandwidth was 1.0 nm, sensitivity was 100 mdeg, response time 
was set at 16 sec, the scan speed was set at 1 nm/min, step resolution was at 0.2 nm and 
data were accumulated at a setting of 2. Noise reduction was applied to all spectra. The 
degree of helicity was estimated as described by Shai et al. (1990), and Perczel et al. 
(1992). 
36 
Determination of Iron-binding Properties 
Iron binding properties were determined using the methods of Chen et al. (1993), 
and Kirby et al. (1998). Briefly, the 35 kDa protein was reconstituted with iron by 
dialyzing the protein against 0.1 M sodium citrate, 0.1 M sodium bicarbonate buffer pH 
8.6. A 25-fold molar excess of ferric chloride was added to the protein solution and the 
solution was incubated at room temperature for 10 minutes. The solution was then 
dialyzed against two overnight changes of 10 mM Tris, 200 mM sodium chloride, and 
pH 8.0. 
The apo-form of the 35 kDa protein was prepared by dialyzing the protein in 0.1 
M sodium acetate, 0.1 M NaHzPC^pH 5.5 for 3.5 hours, then dialyzing against two 
overnight changes of 0.1 M sodium acetate, 0.1 M NaHiPC^, 25 mM NazEDTA, and 
0.4 % (w/w) Chelex 100, pH 5.5, and one overnight change of 10 mM Tris, 200 mM 
sodium chloride, pH 8.0. 
Protein concentrations were determined using the Folin phenol reagent (Lowry et. 
al., 1951). A wavelength spectral scan from 300 to 700 of the holo and apo-forms 
(ferrated and deferrated forms) of the 35 kDa protein was conducted on a Beckman DU-
640 spectrophotometer. 
Enzyme-linked Immunosorbent Assay (ELISA) 
The ELISA procedure was that of Tabatabai and Deyoe (1984). The optimal 
antigen concentration (17 pg/ml) was determined from a protein titration curve obtained 
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from two-fold dilutions of protein and a fixed (1:100) dilution of positive and negative 
bovine antisera. Microliter plates (Nunc-Immuno Plate Maxisorp, Fisher Scientific, 
Hanover Park, IL) were coated with 100 pi of two-fold serially diluted 35-kDa protein in 
0.5 M sodium bicarbonate, pH 9.6 and stored overnight at 5°C. 
Plates were washed (BioRad Immunowash Model 1250) five times for one minute 
with 200 pi of solution containing 0.85 % (w/v) NaCl and 0.05 % (w/v) Tween 80 (Difco 
Laboratories, Detroit, Michigan). Convalescent and normal sera were diluted 1:100 with 
a solution consisting of 0.85 % (w/v) NaCl in 50 mM phosphate, pH 7.5 and 0.05 % (v/v) 
Tween 80 (PBS-Tween) and dispensed in plates in 100 pi quantities and incubated for 2 
hours at room temperature. The washing procedure was repeated and horseradish 
peroxidase-conjugated rabbit anti-bovine IgG (Cappel, West Chester, PA, heavy and light 
chain specificity not determined) was diluted 1:500 in PBS-Tween. Plates were 
incubated overnight at 5°C. The washing procedure was repeated, including a final wash 
with deionized water. 
The enzyme reaction was initiated by adding 100 pi of substrate solution 
containing 5 mM hydrogen peroxide and 0.2 mM [2,2'-azino-di-(3-ethylbenzthiazoline-
6-sulfonic acid), ABTS] (Sigma Chemical Co., St. Louis, MO) in 50 mM sodium citrate 
(pH 4.0). After exactly 10 minutes of incubation at room temperature, the reaction was 
stopped by the addition of 100 pi of 1 mM sodium azide (the enzyme reaction was linear 
with time for 15 minutes). The absorbance ratio at 405 nm/450 nm (to minimize plate to 
plate variation) was measured with a CERES model 900 plate reader (Bio Tek 
Instruments, Winooski, VT). 
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Bovine Antiserum 
For the immunoblotting experiments, pooled sera were obtained from 10 feed 
yard calves three days after experimental infection with P. haemolvtica serovar Al (sera 
from acutely infected animals), and sera collected two weeks post-infection (sera from 
convalescent animals). The logz indirect hemagglutination (IHA) titers (Frank and 
Smith, 1983) ranged from 4 to 7 for the infected calves and from 7 to 10 for the 
convalescent calves. A pooled serum from non-infected, non-vaccinated cattle was used 
as a negative control. These bovine sera were also used for titration experiments of the 
35-kDa PIRP for the ELISA studies. 
Additional bovine sera were kindly provided by Dr. Robert Briggs (National 
Animal Disease Center, Ames, Iowa). The sera were obtained from a field trial of a 
leukotoxin deletion mutant vaccine developed by Drs. Robert Briggs and Fred Tatum. 
The vaccine was administered intramuscularly or mixed with the feed (Briggs and Tatum, 
1999, personal communication) and vaccinated on day 0 and challenged-exposed on day 
21 post-vaccination. Sera were obtained on the day of vaccination and at 21, 28 and 32 
days post-vaccination. 
Rabbit Antisera Production 
Purified 35-kDa protein in phosphate buffered saline was mixed with Freund's 
incomplete adjuvant (Difco) at a ratio of 1:9 of protein to adjuvant to a final 
concentration of 200 fig protein/ml. Rabbits were inoculated subcutaneously in the 
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scapular region with two 0.5 ml injections two weeks apart over a six-week period. Pre-
immunization serum and serum after the second and third inoculations were tested for 
anti-35 kDa protein IgG production by an enzyme-linked immunoassay (Tabatabai and 
Deyoe, 1984), using 100 ng/well of a periplasmic protein preparation containing the 35-
kDa protein. 
Analysis of Siderophore Production in Liquid Culture and on Agar 
Both P. haemolvtica A1 and Pseudomonas aeruginosa (ATCC 27853) were tested 
for siderophore production. P. aeruginosa served as a positive control. Chrome Azurol S 
(CAS) assay solutions and RPMI media were used for the determination of the 
production of siderophores in liquid medium and for the determination of siderophores on 
solid medium. The CAS solutions and medium were prepared as described by Schwyn 
and Neilands (1987). All utensils were plastic, and all solutions were made with E-Pure 
water (Bamstead model D4641). 
The CAS and hexadecyltrimethylammonium bromide (HDTMA) was purchased 
from Fluka Chemical corporation. Anhydrous piperazine, succinic acid, HEPES, and 
5-sulfosalicylic acid was from Sigma (St. Louis, MO). The CAS-Iron (III)-HDTMA 
reagent was prepared by adding the following solutions to a 100-ml volumetric flask, and 
by bringing to volume up to 100 ml with E-pure water: 7.5 ml of 2 mM aqueous CAS, 6 
ml of lOmM HDTMA, 1.5 ml of 1 mM FeCb.ôHzO, 10 mM HC1, this solution was 
stirred constantly. 
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The piperazine buffer was made by dissolving 4.307 g piperazine in 30 ml E-pure 
water, and the pH was adjusted to 5.6 by addition of 6.25 ml concentrated HCL. The 
aqueous piperazine solution was carefully added to the volumetric flask. All solutions 
were stored in polyethylene bottles, at room temperature, and in the dark. 
Cultures were grown in 25 ml RPMI-1640 medium (control) and in RPMI-1640 
medium containing 50 pM 2,2-dipyridyl for 34 hours at 37°C. Aliquots of broth culture 
(1.5 ml) were removed at 0, 2,4, 6, 8, 10, 12,14, 16,24, and 34 hours of incubation. 
Culture samples were centrifuged for 5 minutes at 15,000 x g. A 0.5 ml aliquot of culture 
supernatant (siderophore containing solution) was mixed with 0.5 ml CAS assay solution. 
Absorbance at 630 nm was recorded at 0, 0.5, 1,2, 3,4, 5, and 6 hours of incubation with 
CAS assay solution. The control was prepared identically. 
The CAS agar medium was prepared in a similar manner. A solution of CAS-
HDTMA-Iron (HI) was made by dissolving 60.5 mg of CAS in 50 ml of E-Pure water, 
then 10 ml of 1 mM FeCla.ôHaO, 10 mM HC1 was added, followed by the addition of 40 
ml of 10 mM HDTMA while slowly stirring. Next, 15 g of Noble agar was added to 700 
ml of 25 mM HEPES buffer pH 7.2. The above solutions were autoclaved at 121°C, and 
17 psi for 15 minutes. After autoclaving the solutions were placed in a 50°C waterbath. 
One package of RPMI-1640 was dissolved in 150 ml of 25 mM HEPES buffer pH 
7.2 and brought up to 200 ml with E-Pure water, stirred well and filter-sterilized using a 
0.22 n membrane. All solutions were held in a 50°C water bath for 30 minutes before 
combining all components. 
Plates were poured using 30 ml/petri dish. Petri plates were allowed to cool at 
room temperature then stored at 4°C. Cultures were streaked on the CAS agar plates and 
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checked after growing for 20 hours at 37°C. Cultures were considered positive for 
siderophore production if a yellow halo appeared around the colonies. 
Growth ofP. haemolvtica With Inorganic Iron and Protein-bound Iron 
Ferric chloride and ferrous sulfate were from Fisher Chemicals, transferrin, 
lactoferrin, hemoglobin, and hemin were from Sigma Chemical Company. All of these 
compounds were made up to contain 30 pM iron and were dissolved in deionized water 
and sterilized by filtration. An exponential-phase culture of P. haemolvtica Al in RPMI-
1640 broth buffered with 25 mM HEPES at pH 7.2, was diluted to an absorbance of 0.05 
at 600 nm with fresh RPMI-1640 broth. Fifty gl samples of the diluted culture were 
evenly spread on the surface of freshly prepared, dry RPMI-1640 agar plates, containing 
50 mM 2,2'-dipyridyl to chelate free iron. Whatman filter paper disks (1-cm diameter) 
were sterilized, and impregnated with 25 pi of the various iron-containing solutions, 
placed on the agar surface and incubated at 37°C with or without a 5% CO2 humidified 
atmosphere. Growth of P. haemolvtica Al around the filter disks was recorded after 20 
hours of incubation at 37°C. 
Preparation of Biotinylated Transferrin, Lactoferrin, and Hemoglobin 
Two mg of bovine transferrin, lactoferrin, and hemoglobin were dissolved in I ml 
of 50 mM sodium bicarbonate buffer (pH 8.5) in 16 x 125 mm test tubes. Immediately 
prior to use, 1 mg of sulfosuccinimidyl-6-(biotinamido) hexanoate (Sulfo-NHS-LC-
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Biotin), (Pierce) was dissolved in 1 ml of E-Pure water. Seventy-four pi of the Sulfo-
NHS-LC-Biotin was added to the transferrin, lactoferrin, and hemoglobin solutions. The 
test tubes were placed on ice and incubated for two hours. The biotinylated transferrin, 
lactoferrin, and hemoglobin were dialyzed to remove un-reacted biotin. The biotinylated 
proteins were stored at —20°C until ready for use. 
Detection of Transferrin, Lactoferrin and Hemoglobin Receptors 
Colonies of P. haemolvtica around the edges of filter papers containing iron 
supplied as inorganic iron or protein-bound iron were lifted using BioTrace NT Blotting 
Membrane (Gelman Sciences, Ann Arbor, MI). Colonies attached to the nitrocellulose 
membrane were lysed with SDS lysing solution that contained 10 % SDS. 
The membranes were washed with 0.85 % (w/v) NaCl in 50 mM phosphate, pH 
7.5 and 0.05 % (v/v) Tween 80 (PBS-Tween) five times for five minutes and blocked 
with 0.25% fish gelatin in PBS-Tween for 15 minutes. The membranes were incubated 
with biotinylated transferrin, biotinylated lactoferrin and biotinylated hemoglobin, at a 
dilution of 1:25 in PBS for 30 minutes at room temperature, then washed with PBS-
Tween five times, five minutes per wash. 
Next, the membranes were incubated with avidin-conjugated horseradish 
peroxidase at a dilution of 1:1000 in PBS-Tween, at room temperature for two hours. 
Again, the membranes were washed five times for five minutes per wash. Lastly, the 
membranes were incubated with a substrate solution that contained 20 ml of 0.1 M PBS, 
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pH 7.2,4 ml of 0.3% (w/v) 4-chloronaphthol (Sigma, St. Louis, MO.), in methanol and 
0.01% hydrogen peroxide. Color development was stopped after 15 min by washing the 
membrane extensively in E-pure water. Controls were prepared by incubation of 
similarly prepared membranes with non-biotinylated transferrin, lactoferrin, and 
hemoglobin. 
Cosmid Library Screen 
The Cosmid library consists of cosmid DNA inserts of the P. haemolvtica genome 
packaged in E. coli HB 101 which was produced by Briggs et al., (1994). Frozen stock 
cultures maintained at —70°C were thawed and 10 pi of cell suspension was placed into 
990 pi of 2XYT broth (Maniatis, et al. 1982; and Atlas and Parks, 1993). Fifty 
microliters of 10-fold serial dilutions were spread onto RPMI-1640 agar plates that 
contained 10 mg/ml tetracycline per plate. Plates were incubated overnight at 37°C. 
Plates containing 350-400 colonies/plate were selected for colony lifts. 
Prior to beginning the colony lift procedure, the selected plates were placed at 4°C 
for thirty minutes. Dry Bio Trace NT (Gelman Sciences) nitrocellulose membranes (82 
mm disc) were placed on top of the agar surface and the membrane was allowed to wet 
completely. India ink was used to mark the orientation of the membrane. 
The membrane was lifted off the agar, allowed to air dry completely, placed in 
lysis buffer that contained 20 mM Tris, 500 mM NaCl, and 5 % SDS, pH 8.3 and heated 
in a microwave at maximum power for 3 minutes. The membranes were washed 5 times 
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for 5 minutes with 0.1 M PBS, 0.05 % Tween 80, pH 7.2. During the fifth wash the 
membrane was gently scrubbed with a Kimwipe to make sure any excess agar and cell 
debris was removed. Membranes were then washed one more time for 5 minutes in the 
PBS-Tween solution and blocked for 30 minutes at room temperature in PBS-Tween 80 
containing 0.25 % fish gelatin (Norland Labs). E. coli lysate-absorbed rabbit anti-35 kDa 
antibody was added at a dilution of 1:100 and incubated for 2 hours at room temperature. 
The membranes were washed 5 times, 5 minutes each using 0.1 M PBS, 0.05 % Tween 
80, pH 7.2 and incubated for 2 hours at room temperature in goat anti-rabbit IgG 
horseradish peroxidase conjugate (1:1000 in 0.1 M PBS, 0.05 % Tween 80, pH 7.2). 
After incubation, the membranes were washed 5 times for 5 minutes using 0.1 M 
PBS, 0.05 % Tween 80, pH 7.2, at room temperature followed by one final wash with 
0.1 M PBS pH 7.2, for 5 minutes at room temperature. The membranes were developed 
in a substrate solution containing 4 ml of 0.3 % (w/v) 4-chloronapthol and 20 ml of 0.1 M 
PBS, and 10 pi of 30% H2O2, pH 7.2. Placing the membrane in deionized water stopped 
the color development. 
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RESULTS 
Purification and Characterization of the Periplasmic Iron-regulated Protein 
Cells that were grown in the synthetic medium RPMI-1640, with and without the 
addition of 50 pM 2,2-dipyridyl, expressed up-regulated iron-regulated proteins (Fig. 1, 
lanes 2 and 4; see also Tabatabai and Frank, 1997). When the medium was supplemented 
with 30 pM Fe3+ these proteins were down regulated (Fig. 1, lane 3). Expression of the 
35-kDa protein was down regulated in the presence of 30 pM Fe3+ and Fe2+, but 
expression was not affected by the divalent metal cations Cu2+, Co2+, Ni2+, Mn2+' and 
Zn2+ (Fig. 2). The cell pellets had been suspended in 20 mM HEPES buffer pH 7.2 and 
stored at -20° C. Up to this point P. haemolvtica remained viable when thawed and 
cultured on blood agar. Interestingly, the same cell pellet could be used to extract 
periplasmic proteins three times. Proteins continued to be synthesized and released upon 
thawing and incubation at 37° C (Fig. 3). 
The osmotic shock fluids, rather than whole-cell lysates, were used as starting 
materials for the purification of the 35-kDa protein. The 35-kDa protein was purified 
from 100 mg of protein extract (from 40 g wet weight cells) by CM-Sepharose 
chromatography (Fig. 4). The 35-kDa protein eluted at 225 mM NaCl and the pooled 
concentrated fractions (0.2 mg) show a single band by SDS-PAGE (Fig. 5, lane 3). A 
total of 2 mg of purified protein was obtained from separate chromatography runs. 
Expression of the 35-kDa protein was conserved in all P. haemolvtica serovars 
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Fig. 1. Coomassie Blue-stained SDS-PAGE of the periplasmic proteins prepared from P. haemolvtica. 
Cells were grown in RPMI-1640, overnight at 37° C. Each well contained 5 ng of protein. Lane 1, 
molecular weight markers, molecular weights are shown on the left in kiiodaltons; lee 2, protein profile 
(no iron added to medium); lane 3, protein profile (30 pM FeCl3 added to medium); lane 4, protein profile 
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Figure 2. The effect of metal cations on the expression of the 35-kDa periplasmic iron-
regulated protein. Panel A, Coomassie Blue-stained SDS-PAGE gel of the periplasmic 
proteins expressed in the presence of the 30 pM metal ion. MW, molecular weight 
markers, molecular weights are shown on the left in kilodaltons; Con, control medium 
(no addition of metal cation); remaining lanes, metal ions as indicated. Panel B, Western 
blot reacted with anti-35 kDa rabbit serum. MW, molecular weight markers; Con, 









Figure 3. Coomassie Blue-stained SDS-PAGE of periplasmic proteins expressed by P. 
haemolvtica after storage at -20°C in 20 mM HEPES buffer pH 7.2. Cells were thawed, 
slowly stirred at 37°C and released proteins were removed after three consecutive 20 hour 
incubations. Each lane contains 10 pi of denatured cell extract. Lane 1, molecular 
weight markers, molecular weights are shown on the left in kilodaltons; lane 2, proteins 
after the first incubation; lane 3, proteins after the second incubation; and lane 4, proteins 
after the third incubation. 
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Fig. 4. Purification of the 35-kDa periplasmic iron-regulated protein by CM-Sepharose 
chromatography. Ten mg protein prepared from the osmotic shock fluids was precipitated 
with ammonium sulfate between 50 % and 80% saturation and applied to a 1 x 12 cm 
column packed with CM-Sepharose. The column was equilibrated with 20 mM MES, pH 
5.5. The proteins were eluted with a linear gradient from 0 to 1 M NaCl in 20 mM MES, 
pH 5.5. The solid line (—) indicates absorbance at 280 nm; the dashed line 
(- -) indicates the NaCl gradient; the shaded area corresponds to the pooled fractions 









Fig 5. Coomasie Blue-stained SDS-PAGE of the purified 35-kDa periplasmic iron-
regulated protein. Samples were denatured and loaded onto the SDS-PAGE gel as 
described in Materials and Methods. Each lane contains 5pg of protein. Lane 1, 
molecular weight markers, molecular weights are shown on the left in kilodaltons; lane 2, 
original extract; lane 3, pooled fraction after CM-Sepharose ion exchange 
chromatography. 
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(serovars Al, A2, A5 through A9, Al 1 through A14, and A16. However, P. trehalosi 
serovars T3, T4, T10, and T15 (formerly classified as P. haemolvtica serovars T3, T4, 
T10, and T15) (Sneath and Stevens, 1990), expressed weakly reacting 35-kDa proteins as 
revealed by Western blots using antiserum prepared to the 35-kDa protein from P. 
haemolvtica serovar A1 (Fig. 6). 
Isoelectric focusing of the 35 kDa protein on a pH 4 to 6.5 gradient IEF gel and a 
pH 3 to 9 gradient IEF gel showed multiple bands (Fig. 7). The results using the pH 4 to 
6.5 gel showed three minor bands with pis of 5.5, 5.6, 5.8, and a major band with a pi of 
6.4 (Fig. 7, Panel A, lane 2). On the IEF gel with a pH gradient from pH 3 to 9, the gel 
showed three minor bands with pis of 5.3, 5.7, and 6.5, and a major band with a pi of 6.8 
(Fig. 7, panel B, lane 2). In order to rule out that multiple bands resulted from limited 
proteolysis, the protein was also subjected to native PAGE using a 7.5% acrylamide gel. 
Degradation of the protein would indicate multiple bands. However, the results showed a 
single, but somewhat broad band of medium mobility (Fig. 7, panel C, lane 2). 
The molecular weight of the purified iron-regulated protein was estimated using 
several methods (Table 1) including SDS-PAGE (35,360, Fig. 3), MALDI-TOF (35,980, 
Fig. 8), ES-MS (35,822, Fig. 9), and equilibrium velocity ultracentrifugation (33,795) 
(Fig. 10). The apparent molecular weight that was calculated from the equilibrium 
velocity data indicated that the protein existed as monomers in solution under non 
denaturing conditions. The lack of association of protein monomers is shown as a 
random distribution of the residuals around the mean (Fig. 10, upper panel). 
Determination of the secondary structure of the 35-kDa protein by circular 
dichroism revealed that the protein contained 34.1% alpha helical structure, 
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Figure 6. Western blot showing conservation of expression of the 35-kDa periplasmic 
iron-regulated protein purified from P. haemolvtica serovar A1. Cells were grown in 
RPMI-1640 as described in Fig. 1 legend. Lanes contained 3|ig protein/well. After 
electrophoresis the protein bands were transferred to nitrocellulose. The membrane was 
probed with rabbit antiserum to the 35-kDa protein. Panel A, M.W., Amido Black-
stained molecular weight markers; 35 P, purified 35-kDa protein; Al, A2, A5, A6, and 
A7, periplasmic proteins from P. haemolvtica serovars Al, A2, A5, A6, and A7; T3 and 
T4, periplasmic proteins from P. trehalosi serovars T3, and T4. Panel B, M.W., Amido 
Black-stained molecular weight markers; 35 P, Amido Black-stained purified 35-kDa 
protein; A8, A9, Al 1, A12, A13, A14, and Al6 periplasmic proteins from P. haemolvtica 
serovars A8, A9, Al 1, A12, A13, A14, and A16; TIO and T15 periplasmic proteins from 







Figure 7. Isoelectric focusing and native PAGE of purified 3 5 -kDa periplasmic iron-
regulated protein. Panels A and B, isoelectric focusing, Panel C, native PAGE. Samples 
containing 1 pg of protein in 15 pi were deposited onto 2 mm x 5 mm Whatman No. 1 
filter papers. Panel A, IEF gel with pH gradient from pH 4 to pH 6.5; lane 1,isoelectric 
focusing standards from Sigma; lane 2, purified 35-kDa protein. Panel B, isoelectric 
focusing gel with pH gradient from pH 3.5 to pH 9.5; lane 1,isoelectric focusing standar 
from Sigma; lane 2, purified 35-kDa protein. Panel C, native PAGE 7.5% homogeneous 
gel; lane 1, nondenatured periplasmic proteins; lane 2, nondenatured purified 35-kDa 
protein. Arrow denotes the band of the 35-kDa protein on the native gel. 
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Table 1. Comparison of molecular weights obtained by various methods. 





Equilibrium Velocity 33,795 
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Figure 8. MALDI-TOF of the 35-kDa protein. The protein (0.33 pi) at a concentration of 
0.25 mg/ml was mixed with an equal volume of saturated sinapinic acid in 50% 
acetonitrile-0.1% trifluoroacetic acid. After drying at ambient temperature a 0.33 pi of 
10% formic acid was added and allowed to dry. The mass spectrum was obtained using a 
Lasermat 2000 (Finnigan) at 50% laser power. Bovine serum albumin (Mr = 66,000) was 
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Figure 9. Electrospray mass spectrometry of the 35-kDa protein. Desalted protein was 
concentrated to 1 mg/ml then diluted to a concentration of 0.5 mg/ml with 50% (v/v) 
methanol and 1% (v/v) acetic acid. One hundred microliter of protein was injected. The 
mass spectrum was obtained using a Finnegan MAT TSQ 700 mass spectrometer. Insert 





Figure 10. Equilibrium velocity ultracentrifugation of the purified 35-kDa protein. The 
protein was at a concentration of 0.5 mg/ml in 20 mM MES buffer pH 5.5, 0.2 M NaCl. 
The Beckman XL-A Maxima Optima was fitted with a monochrometer and the changes 
in the boundary were measured at 280 nm. Equilibrium centrifugation was conducted at 
2°C, using a rotor speed of20,000 rpm. Upper panel shows the distribution of the 
residuals, while the lower panel shows the sedimentation equilibrium distribution of the 
35 kDa protein. 
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16.8% p sheet, 31.1% (3 turn, and 17.9% random structure (Fig. 11). 
The immunoreactivity of the 35-kDa protein was assayed by Western blotting 
using sera from normal, infected and convalescent cattle. Only the sera from the 
convalescent cattle showed a strong reaction with the protein (Fig. 12). 
N-terminal Sequence Analysis and Identity of the 35-kDa Protein 
A single N-terminal sequence (ANEVNVYSYRQPYLIEPMLK) was obtained for 
the 35-kDa protein (Fig. 13, preliminary results reported by Belzer et al. 1996). This 
sequence was later found to be identical to the deduced amino acid sequence of the FbpA 
of P. haemolvtica serovar Al (Fig. 14) (Accession no. gi3978164) (Kirby et al., 1998). A 
database search using BLAST 2.0 with the FbpA of P. haemolvtica revealed that the 
greatest identity, 41%, was with Svnochocvstis sp. iron binding protein (Accession no. 
BAA16842), and 23% identity with the ferric-binding protein from H. influenzae 
(Accession no. 1MRP of the protein data base, pdb) (Bruns et al., 1997). 
Comparison of the N-terminal sequence of the mature protein (Figure 13) with the 
deduced amino acid sequence (Figure 14) indicates the protein has a 22-amino acid signal 
peptide. A comparison of the amino acid composition of the 35-kDa and the deduced 
amino acid composition of the 35-kDa FbpA is shown in Table 2. The amino acids 
cysteine and tryptophan were not determined by the amino acid analysis procedure used. 
In comparing the two sequences (Table 2), the results are quite similar except that the 35-
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Figure 11. Circular dichroism of the 35-kDa protein. The sample was dissolved in 10 
mM HEPES pH 7.2, 100 mM KC1 at a concentration of 0.35 mg/ml. Spectra were 
obtained using a Jasco J-710 spectropolarimeter. The wavelength scan was from 190 to 
260 nm using a 0.1 cm cell. The bandwidth was 1.0 nm, sensitivity was 100 mdeg, 
response time was 16 sec, the scan speed was 1 nm/min, step resolution was 0.2 nm and 
data were accumulated at a setting of 2. Noise reduction was applied to all spectra. The 
degree of helicity was estimated as described by Perczel et al. (1992). 
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Figure 12. Western immunoblot of the 35-kDa periplasmic iron-regulated protein with 
pooled bovine sera. Pooled bovine sera from nonnal, actively infected, and convalescent 
animals were used to develop the Western blots containing the 35-kDa protein. Panel A 
was stained with Amido Black; lane 1, molecular weight marker, lane 2, periplasmic 
proteins. Panel B was developed with pooled normal bovine sera; lane 1 periplasmic 
proteins; lane 2,50-80% ammonium sulfate fraction of the periplasmic proteins; lane 3, 
purified 35-kDa protein. Panel C was developed with pooled convalescent bovine sera; 
lane 1, periplasmic proteins; lane 2, 50-80 % ammonium sulfate fraction; lane 3, purified 
35-kDa protein. Panel D was developed with pooled sera from acutely infected cattle; 
lane 1, periplasmic proteins; lane 2, 50-80 % ammonium sulfate fraction of the 
periplasmic proteins; lane 3, purified 35-kDa protein. 
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Figure 13. N-terminal amino acid sequence of the purified 35 kDa iron-regulated 
protein. The N-terminal amino acid sequence was determined from protein blotted to 
a PVDF membrane. 






Figure 14. Deduced amino acid sequence of the Mannheimia haemolvtica iron binding 
protein homologue, FbpA, obtained from the NCBI data bank search. 
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Table 2. Comparison of the amino acid composition of the 35-kDA PIRP and the 
deduced amino acid compositon of the 35-kDa FbpA from Pasteurella haemolvtica. 
Residue Number of residues per mole 
35-kDa PIRP" 35-kDa FbpAb 
Asp + Asn 46 39 
Glu + Gin 32 34 
Ser 20 19 
Gly 44 23 
His 2 5 
Arg 11 10 
Thr 8 9 
Ala 30 27 
Pro 9 11 
Tyr 13 16 
Val 22 23 
Met 2 4 
He 21 23 
Leu 25 24 
Phe 11 11 
Lys 30 37 
Cys _C 2 
Trp c 3 
Total 327 320 
•PVDF results 
^Calculated results from data of Kirby et al (1998) 
«Not determined 
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Analysis of Siderophore Production in Liquid Culture and on Agar 
One method commonly used to detect siderophores is growing the micro­
organism in iron-limited media. Several investigators (Ogunnariwo and Schryvers, 
(1990), Reissbrodt et. al. (1994), and Diarra et. al. (1996)) reported that P. haemolvtica 
did not produce siderophores. In order to confirm that P. haemolvtica did not produce 
siderophores we used two methods described by Schwyn and Neilands (1987), to assess 
siderophore production. The first method is the CAS assay of broth culture. The CAS 
assay is a highly sensitive chemical method to detect and measure siderophore production 
based on their affinity for iron (HI). Since chelators in the growth media interfere with 
the assay, we also measured the effect of 2,2'-dipyridyl on the CAS assay (Figure 15). 
As shown in Figure 15, addition of 2,2'-dipyridyl causes a decrease in absorbance due to 
chelation of iron by 2,2'-dipyridyl from the CAS reagent in a time-dependent fashion. 
The decrease in absorbance levels off after three hours of incubation at room temperature. 
Therefore, the 3 hour time point was used to check for production of siderophore over a 
36 hour period of growth. In Figure 16, P. haemolvtica and Pseudomonas aeruginosa 
(ATCC 27853) are compared for siderophore production as measured by the CAS assay. 
The results show that R haemolvtica supematants caused a gradual decrease in 
absorbance at 630 nm over a period of 36 hours. The positive control culture of P. 
aeruginosa produced siderophores as shown by an immediate decrease in absorbance at 
630 nm. 
The second method is the CAS assay on solid medium. P. haemolvtica did not 
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Figure 15. Effect of2,2'-dipyridyl on the CAS assay. P. haemolvtica was grown in 
RPMI 1640 broth for 36 hours in the absence and in the presence of2,2'-dipyridyl. The 
ratio of absorbance of the control medium divided by the absorbance of the test sample 
obtained at various incubation times was plotted as a function of time. P. haemolvtica 
grown in the absence of 2,2'-dipyridyl (-0-); and P. haemolvtica grown in the presence 
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Figure 16. Siderophore production in the culture supernatant as measured by the 
CAS assay. P. haemolvtica and P. aeruginosa were grown in RPMI 1640 broth for 
up to 36 hours in the absence and in the presence of 2,2'-dipyridyl. P. haemolvtica 
in the absence of 2,2'-dipyridyl (- O -); and P. haemolvtica in the presence of 
2,2'dipyridyl (- • -); P. aeruginosa in the absence of 2,2'-dipyridyl (-0-); and P. 
aeruginosa in the presence of 2,2'-dipyridyl (-A-). 
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surrounding yellow halo characteristic of siderophore production (Figure 17). 
Growth ofP. haemolvtica with Inorganic Iron and Protein-bound Iron 
P. haemolvtica was grown on RPMI-1640 agar in either NaHCOs or HEPES 
buffer in the presence of various iron sources, and in the presence and absence of 2,2'-
dipyridyl as described in the Material and Methods. P. haemolvtica utilized all iron 
sources except hemin (Table 3). P. haemolvtica was also grown on RPMI-1640 agar in 
the presence of 50 |xM 2,2'-dipyridyl with the same iron-containing compounds being 
applied to a filter paper disk at a concentration of 30 |iM, (Figure 18) and after 20 hours 
the P. haemolvtica plates were checked for growth. P. haemolvtica utilized the ferric ion 
from ferric chloride, and iron bound by transferrin, lactoferrin and hemoglobin. When R 
haemolvtica was grown on CAS agar or RPMI 1640 agar with or without 2,2'-dipyridyl 
the resultant growth always appeared as micro colonies (Figure 18), suggesting the 
medium was not optimal for P. haemolvtica. 
Demonstration of Bovine Transferrin, Lactoferrin and Hemoglobin Receptors 
Because P. haemolvtica was able to obtain iron from transferrin, lactoferrin, and 
hemoglobin, an assay was set up to examine the up-regulation of transferrin, lactoferrin, 
and hemoglobin receptors. Utilizing the plaque lift technique, colonies were lifted onto 
nitrocellulose as described in the Material and Methods. Biotinylated bovine transferrin 
(BT), biotinylated bovine lactoferrin (BL), and biotinylated bovine hemoglobin (BHb) 
were incubated with P. haemolvtica colony lifts. Figure 19 shows binding of biotinylated 
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Figure 17. P. haemolvtica streaked on CAS agar plates and incubated at 37° C 
for 20 hours. P. haemolvtica does not possess the characteristic halo seen 
around the colonies when a bacterium is a siderophore producer. 
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Table 3. The effect of different iron sources on the growth of P. haemolvtica 
on RPMI-1640 agar. 
5% CO, 







* Chromeazurol S in HEPES buffer, pH 7.2 
b Chromeazurol S in sodium bicarbonate buffer, pH 7.2 
c RPMI 1640 in HEPES buffer, pH 7.2 
d RPMI 1640 in HEPES buffer containing 2,2'dipyridyl pH 7.2 
e RPMI 1640 in sodium bicarbonate buffer, pH 7.2 
fRPMI 1640 in sodium bicarbonate buffer containing 2,2',dipyridyl, pH 7.2 
+ + + + + 
- + » + + 
+ + + + 
+ + - + - -
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Figure 18. Plate bioassay for growth stimulation of P. haemolvtica bv various iron 
sources. The culture media was RPMI-1640 (HEPES) agar containing 50 nM 
2,2'-dipyridyl. Each iron source contained 30 pm iron. Disks contained (from bottom 
clockwise) FeCl3, ferric chloride; FeS04, ferrous sulfate; (H), hemin; (HB), hemoglobin; 
(T), transferrin; and (L), lactoferrin. 
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FeClg+BT BT BHb BL 
Figure 19. Identification of receptors in P. haemolvtica A1 for transferrin, 
hemoglobin and lactoferrin. Growth around the iron-containing disks were 
lifted using nitrocellulose as described in Materials and Methods. 
Nirocellulose-bound whole cell lysates were incubated with 
non-biotinylated transferrin (T); hemoglobin (Hb); and lactoferrin (L); and 
biotinylated transferrin (BT); biotinylated hemoglobin (BHb); and 
biotinylated lactoferrin (BL). Bound biotinylated proteins were detected 
after incubation with horseradish peroxidase-conjugated avidin followed 
by color development using H2O2 and 4-chloronapthol. 
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transferrin, lactoferrin, and hemoglobin to P. haemolvtica cell lysate proteins. The results 
show that under iron-deficient conditions, P. haemolvtica up-regulates receptors for 
transferrin, lactoferrin, and hemoglobin, (Fig. 19). 
Determination of Iron-binding by the 35-kDa Protein 
Iron binding by the 35-kDa protein was determined using the methods of Chen et 
al. (1993), and Kirby et al. (1998). A wavelength spectral scan (Fig. 20) from 300 to 700 
nm of the ferrated and deferrated forms of the 35 kDa protein shows an increase in 
absorbance of the ferrated form between 300 and 600 nm with a maximum difference at 
425 nm. The increase in absorbance at 425 nm suggest a protein-Fe(m) complex (Kirby 
et al., 1998). 
Enzyme-linked Immunosorbent Assay (ELISA) 
The western blot showed that the sera from the convalescent group of calves had high 
antibody response to the 35-kDa protein (Fig. 12), therefore, the ELISA was performed to 
assess if an experimental infection with P. haemolvtica had elicited an antibody response 
to the isolated 35-kDa PIRP. Figure 21 shows the optimal protein concentration (1.7 
gg/well), which was determined by using a protein titration curve. The average 
absorbance of the sera from each group was determined for each sampling date (Fig. 22). 
Since the control group showed a high level of antibody towards the isolated 35-kDa 
PIRP (data not shown), the data was plotted as a mean absorbance change from day 0 
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Smoothing: None 







300.0 Wavelength (nm) 700.0 
Figure 20. Wavelength spectral scan from300 to 700 nm of the ferrated (upper trace) 
and deferrated (lower trace) forms of P. haemolvtica 35 kDa protein. 
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35 kDa protein (fig/well) 
Figure 21. Titration curve of P. haemolvtica 35 kDa protein by the ELISA method. The 
enzyme immunoassay was performed with pooled bovine serum from convalescent 
animals (•), and normal bovine serum (O) as the primary antibodies, and goat anti-
bovine horseradish peroxidase-conjugated anti-bovine IgG as the secondary antibody. 
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Figure 22. ELISA of the postvaccinal IgG response to P. haemolvtica 35 kDa protein. 
Animal groups (four/group) consisted of controls (—), those administered vaccine IM (-
), and those fed the vaccine (—). Horseradish peroxidase-conj ugated anti-bovine IgG 
was used as the secondary antibody. 
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(Fig. 22). These results suggest that the animals had prior exposure to the P. haemolvtica 
organism prior to vaccination with the P. haemolvtica. These data show that the 
experimental vaccine had induced an antibody response to the 35-kDa protein in the 
vaccine preparation in some but not in all animals. The ELISA mean absorbance change 
from day 0 to day 32 was not statistically significant between groups as indicated by the 
overlapping standard deviation bars. The group exhibiting the greatest antibody response 
to the 35-kDa protein on day 32 was in the calves that had been fed the vaccine (Fig. 22). 
Cosmid Library Screen 
The cosmid library consists of cosmid DNA inserts of the P. haemolvtica genome 
packaged in E. coli HB 101 which was produced by Briggs et al., (1994). Ten plates 
containing 350-400 colonies/plate were screened. Colony lifts were done on all plates. If 
the clones were positive (selected by color development), the colonies were picked, sub 
cultured, and western blots were run on whole cell Iysates of recombinant E. coli 
expressing the 35-kDa PIRP (Fig. 23). Subsequently, ten positive clones were selected. 
Curiously, the 35-kDa protein from the positive clones, had molecular weights of 34,500 
and 28,500 (calculated from a SDS-PAGE gel). This is slightly lower than the native 





















Figure 23. Western blot of whole cell ly sates prepared from recombinant E.coli 
expressing the 35 kDa protein. Pannel A, lane 1, Amido Black-stained molecular 
weight markers; lane 2, Amido Black-stained 35-kDa purified protein; lanes 3-12, 
postive clones. Pannel B, lane 13, Amido Black-stained 35-kDa purified protein; 
lane 14-23, positve clones. Twenty one positive clones were grown in RPMI 1640 
in 25 mM HEPES buffer pH 7.2 containing 10 mg/ml tetracycline. Cells were 
standardized to an absorbance of 1 at 600 nm, washed in 0 .1 M PBS pH 7.2 two 
times and resuspended in sample buffer. Cells were boiled 5 minutes and 10 pi of 
sample was loaded per lane on an SDS PAGE gel. Gels were blotted to 
nitrocellulose overnight and probed with anti-35 kDa rabbit antibody. 
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DISCUSSION 
In this study we examined the effect of iron limitation on the expression of the 
periplasmic protein involved in iron transport and the expression of the outer membrane 
transferrin/lactoferrin binding proteins. 
We confirmed that P. haemolvtica serotype A1 expressed three periplasmic iron-
regulated proteins (31, 35, and 42 kDa) when grown in a chemically defined medium 
(RPMI-1640) without added iron and in the presence of the chelating agent 2,2'-
dipyridyl. In the absence of 2,2'-dipyridyl in the growth medium (Fig. 1 and Tabatabai 
and Frank, 1997), P. haemolvtica expressed two iron-regulated proteins. The N-terminal 
sequence (ANEVNVYSYRQPYLIEPMLK) of the 35-kDa PIRP was first reported by 
Belzer et al. (1996) as a preliminary communication, and also by Kirby et al. (1996a) 
who presented the gene sequence and the deduced amino acid sequence of the 35-kDa 
iron-regulated protein. A database search then identified the 35-kDa protein as the ferric 
binding protein (FbpA) homologue of the H. influenzae ferric binding protein (Bruns et. 
al. 1997). Recently, Kirby et al. (1998) reported the entire sequence of the gene that 
encodes the P. haemolvtica 35-kDa FbpA homologue. 
The method of preparation of the 35-kDa FbpA from P. haemolvtica serovar A1 
was greatly facilitated by several factors. First, growing the organisms in a chemically 
defined medium facilitated purification and identification of the iron-regulated proteins. 
Second, by using osmotic shock fluids as the starting material, rather than a whole-cell 
lysate, we greatly improved our ability to purify this protein. The molecular weight of 
the 35-kDa FbpA ranged from 35,980 by using MALDI-TOF to 35,360 by using SDS-
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PAGE. The molecular weight of the 35-kDa FbpA under native conditions was 
determined by equilibrium centrifugation. A value of 33,795 Daltons was calculated 
which was in agreement with subunit molecular weight as determined by ES-MS, 
suggesting the protein is a monomer. These results were in agreement with the results of 
Adams and Oxender (1989) and Chen et al. (1993), who showed that periplasmic binding 
proteins were monomeric proteins. 
Even though SDS-PAGE and the other methods used for molecular weight 
determination indicated a single molecular species of approximately 35,000, the IEF 
results showed multiple protein bands on both the pH 3 to 9 gradient gel and the pH 4 to 
6 gradient gel. The multiple bands observed by IEF may be due to limited proteolytic 
degradation or alternatively, due to post-translational modification. Proteolytic 
degradation was ruled out because only one major N-terminal amino acid residue was 
obtained in the first cycle from the protein sequencing run. Post-translational 
modification was considered a possibility. When the entire (deduced) amino acid 
sequence (Kirby et al., 1998), was submitted to the PROSITE database (Nielsen, et al., 
1997), several sequence motifs were identified where post-translational modification 
could occur. For example, there were two potential N-glycosylation sites, eight potential 
protein kinase C phosphorylation sites, and seven potential N-myristoylation sites. 
Studies on the role, if any, of these potential post-translational modification sites on the 
iron transport mechanism(s) will be studied in the future. 
The circular dichroism studies of the 35-kDa FbpA revealed that the protein 
contained 34.1% alpha-helical structure. These results are slightly lower than those 
reported by Adams and Oxender (1989), and Chen et al. (1993), who reported that many 
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periplasmic binding proteins have secondary structures that contain 42 to 45%, alpha-
helical structures. 
The amino acid composition of the native 35-kDa FbpA was similar to the amino 
acid composition calculated from the deduced amino acid sequence of P. haemolvtica 
serovar Al (Kirby et al., 1998), minus the signal sequence of 22 amino acids (Table 2). 
The exception was the Gly content. Gly content of 44 residues/mol was considerably 
higher than the Gly content calculated from the deduced amino acid composition (23 
residues/mol) (Kirby et al. 1998). The higher Gly content probably reflected retained Gly 
by the blot, even though the blot was extensively washed with deionized water. The N-
terminal sequence and amino acid composition of the 35-kDa FbpA, however were 
different from the sequence and amino acid composition of the 31-kDa protein reported 
by Tabatabai and Frank (1997). 
The database search conducted with the deduced amino acid sequence reported by 
Kirby et al. (1998, accession no. gi3978164) revealed 100% identity to the FbpA of 
Pasteurella multocida (accession no. AAK02135), 88% identity to the iron (IE) ABC 
transporter, periplasmic iron-compound-binding protein of Vibrio cholerae (accession no. 
C82302), 82% identity to the AGR_C_346p of Aerobacterium tumefaciens (accession 
no. AAK86021), 76% identity to the putative iron binding protein (PIBP) of 
Sinorhizobium meliloti (accession no. CAC45301), 57% identity to the iron-binding 
protein FbpA precursor-like protein of Brucella melitensis biovar Abortus (accession no. 
AAG18581), but only a 23% identity to the H. influenzae ferric-binding protein (Bruns et 
al., 1997, accession no. pdblMRP) (Table 4). 
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Table 4. Comparison of N-terminal sequence identities of the 35-kDa Pasteurella 
haemolytica protein with other binding proteins. 
Organism Sequence 
P. haemolvtica 35-kDaPIRP* 01 ANEVNVYSYRQPYLIEPMLK20 
P. haemolvtica FbpAb 23 ANEVNVYSYRQPYLIEPMLK 42 
P. multocida FbpAc 40 ANEVNVYSYRQPYLIEPMLK 59 
Vibrio cholerae iron (HI)d 37 AQEVNVYSYRQPFLIEPMFA 56 
Aerobacterium tumefaciens AGRC 43 EGEVNVYSYRQPELIQPLLD 62 
Sinorhizobium meliloti PIBPf 27 DGEVNIYSYRQPDLIQPLLD 46 
Brucella melitensis FbpA8 23 ADEVNLYTTREPGLIQPLLD 42 
"Determined by N-terminal sequencing of the native protein (this work). 
''Accession number gi3978164 (Kirby et al., 1998) 
cAccession number AAK02135 (May et al., 2001) 
dAccession number C82302 (Heidelberg et al., 2000) 
cAccession number AAK86021 (Hinkle et al., 2001) 
^Accession number CAC45301 (Capela et al., 2001) 
8Accession number AAG18581 (Eskra et al., 2000) 
Expression of the 35-kDa FbpA was specifically regulated by Fe2+ and Fe3+ 
because addition of these metal ions to the culture medium down regulated the 35-kDa 
FbpA. Addition of Co2+, Cu2+, Mn2+, Ni2+ and Zn2+ did not result in down-regulation of 
the 35-kDa FbpA. These results suggested that transport of Co2+, Cu2+, Mn2+, Ni2+ and 
Zn2+ was regulated in a different manner presumably involving different transport 
proteins. 
Expression of the 35-kDa FbpA was conserved in all A biovars of P. haemolvtica. 
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but not in the T biovars of P. trehalnsi. as determined from Western blots using antibody 
raised to the 35-kDa FbpA from serovar A1. These data are in agreement with those 
reported for the 31-kDa iron-regulated protein (Tabatabai and Frank, 1997), and support 
the suggestion that P. haemolvtica should be reclassified as a separate genus (Sneath and 
Stevens, 1990; Davies et al., 1996; Angen et al. 1999b). 
Several 35-kDa iron transport proteins and related iron-acquisition proteins have 
been identified in many other pathogenic bacteria. Otto et al. (1994) reported that 
Bacteroides fraeilis had four polypeptides with molecular weights of approximately 60, 
58,49, and 35 kDa involved in the uptake of heme from haptoglobin-haemoglobin and 
were identified as haem-binding proteins. Similarly, Richardson and Parks (1995) found 
that Campylobacter coli expressed a 35-kDa protein coding for a gene that was part of an 
operon encoding components of a periplasmic binding-protein-dependent transport 
system for the uptake of ferric siderophore from Ç coli. In the evaluation of virulence 
plasmids, Actis et al. (1995) found that plasmid Jml contained a fatB gene that encoded a 
35-kDa periplasmic protein that was essential for iron transport. Willemsen et al. (1997), 
also described a 35-kDa periplasmic iron transport protein from Actinobacillus 
actinomvcetemcomitans. designated as AfuA, that had strong homology to HitA and 
FbpA gene products of H. influenzae and Neisseria meningitidis, respectively. 
The Western blotting experiments showed that the 35-kDa FbpA reacted strongly 
with the pooled sera from the convalescent animals. In general, immunoreactive proteins 
are often considered good candidates for inclusion in vaccines and for development as 
diagnostic reagents. Even though the Western blot demonstrates a strong reaction of the 
convalescent serum with the 35-kDa FbpA, we do not believe that the 35-kDa FbpA 
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would have diagnostic potential for identifying acute P. haemolvtica infections, because 
the ELISA data suggested that most calves were exposed to the P. haemolvtica organism 
prior to vaccination with P. haemolvtica. In contrast, the immunoreactive 35-kDa FbpA 
might be considered for further development as a vaccine component to reduce the 
severity of disease due to P. haemolvtica. Vaccination of calves with iron-regulated 
proteins could potentially block iron acquisition or iron transport by Pasteurella 
haemolvtica and possibly reduce colonization by P. haemolvtica. In support of this 
conclusion, Confer et al. (2001) demonstrated that rabbits vaccinated intranasally with an 
outer membrane extract of P. multocida containing IROMP and cholera toxin enhanced 
resistance against experimental pneumonic pasteurellosis. 
Siderophore production is another mechanism for some bacterial organisms to 
obtain iron. We supported previous reports that P. haemolvtica did not produce 
siderophores. The method for the detection of siderophore production includes those for 
the direct measurement of the hydroxamate-type siderophores and the catechol-type 
siderophores. The method used in this study was based on the removal of iron (IE) from 
the chromazuroi S-Fe(IH) complex by a secreted siderophore, resulting in a yellow halo 
around the colony when tested on a solid medium. In broth cultures, a decrease in 
absorbance at 630 nm is observed when iron is removed from the chromazuroi S-Fe(IH) 
complex. 
P. haemolvtica serovar A1 did not produce a halo on CAS agar, and exhibited a 
gradual change in absorbance at 630 nm when broth culture supematants were assayed 
for siderophore production. Pasteurella haemolvtica showed a 15% decrease in 
absorbance after 36 hours of growth, whereas the positive control of P. aeruginosa 
83 
showed a 37% decrease in absorbance after 5 hours of growth. Our results with P. 
haemolvtica were in agreement with the results reported by Ogunnariwo and Schryvers 
(1990), who were not able to detect siderophore production in the CAS assay in broth 
cultures. The gradual decrease observed by us may be due to the production of small 
amounts of low molecular weight metabolites capable of binding iron. Reissbrodt et. al. 
(1994) reported that no hydroxamate or phenolate type siderophores were detected during 
growth of P. haemolvtica or P. multocida. In contrast, Diarra et. al. (1996) who designed 
experiments using eleven synthetic siderophore-Fe(m) complexes, observed that P. 
haemolvtica could acquire iron from these complexes, presumably after uptake of the 
Fe(III)-siderophore complex mediated by the tonB gene product. 
It is now generally accepted that members of the Pasteurellaceae. including P. 
haemolvtica. use a receptor-mediated iron acquisition system to acquire iron from its host 
(Ogunnariwo and Schryvers 1990; Ogunnariwo et al. 1991; Ogunnariwo and Schryvers 
1992; Kirby et. al., 1995; Kirby et. al., 1996b; Gray-Owen and Schryvers, 1996; and 
Ogunnariwo and Schryvers 2001), instead of using the high affinity siderophore system 
(Neilands 1982). 
We showed that under iron restricted conditions P. haemolvtica expresses the 
receptor proteins TbpA-TbpB as measured through the detection of bound biotinylated 
transferrin, biotinylated lactoferrin and biotinylated hemoglobin. We do not know if the 
transferrin receptor complex binds lactoferrin and hemoglobin or if specific receptor 
complexes were expressed. Competitive inhibition experiments using unlabeled 
transferrin, lactoferrin, and hemoglobin might have answered this question. Growth of P. 
haemolvtica from lactoferrin has not been previously reported in the literature. 
84 
The recombinant periplasmic iron transport protein of P. haemolvtica binds iron 
(HI) with an association constant, KA, of 1022 M"1 (Mietzner et al., 1998), whereas the 
affinity constant, Ka, of the recombinant FbpA-iron complex from N. gonorrhhoeae was 
1019 - 1020 M"1 (Mietzner and Morse 1994; and Kirby et al., 1998). We were unable to 
determine the KA of the native FbpA for iron (HI) because we were not able to purify 
sufficient quantities of native protein to perform the citrate competition assay described 
by Chen et al. (1993). However, we had sufficient protein to prepare ferrated and 
deferrated protein for a wavelength scan experiment to determine the increase in 
absorbance at 419 nm, which is indicative of protein-bound iron. Our results were in 
agreement with those reported by Kirby et al. (1998). 
After observing that the 35-kDa was immunoreactive in convalescent calves, we 
entertained the hypothesis that the 35-kDa protein might be a potential diagnostic 
antigen. The 35-kDa FbpA was used as an ELISA antigen to detect antibody to the 35-
kDa FbpA in calves (from a field experiment) that were vaccinated and challenge 
exposed to P. haemolvtica. Our study showed that the 35-kDa FbpA was not a good 
candidate for an ELISA antigen for IgG antibody detection in serum samples obtained 
from a field trial of an experimental P. haemolvtica leukotoxin-deletion mutant vaccine, 
because the control group showed an antibody titer to the 35-kDa protein, suggesting the 
calves had been exposed to P. haemolvtica prior to the vaccine trial or had antibody to 
cross-reacting antigens. 
An attempt was made to clone the gene encoding the 35-kDa FbpA. This was 
done to isolate sufficient protein for the determination of the Ka for the FbpA-iron 
complex and other studies. Expression of the FbpA gene in a cloning vector transacted 
into E. coli showed a protein band with molecular weights of34,500 and 28,500-kDa. 
This is slightly lower than the molecular weight of native FbpA as measured by SDS-
PAGE and could be due to a truncated gene or to limited proteolysis. 
CONCLUSIONS 
A method has been developed for the expression and isolation of native 35-kDa 
periplasmic iron-regulated protein. Biochemical characterization of the 35-kDa showed 
that the FbpA had a molecular mass of 35,822 by ES-MS, an isoelectric point of 6.6, and 
that the 35-kDa FbpA was a monomer in solution under native conditions. Circular 
dichroism studies revealed that the secondary structure of the 35-kDa FbpA contained 
34.1 % alpha helical, 31 % P structure, and 17.9 % random structure. Immunological 
properties of the protein were determined by ELISA and by Western blot. The 35-kDa 
FbpA detected IgG antibody in sera from convalescing calves, but not in actively infected 
calves. The 35-kDa iron-regulated protein is identical to the P. haemolvtica FbpA 
homologue, which has 23% identity to the H. influenzae FbpA iron-transport protein. 
Iron limitation resulted in up-regulation of the 35-kDa protein and in an increase 
in the expression of transferrin/lactoferrin/hemoglobin receptor proteins. We suggest that 
the 35-kDa FbpA could be considered one of the virulence factors for P. haemolvtica in 
that this protein may be crucial for microbial survival. Therefore the 35-kDa FbpA might 
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be a potential vaccine candidate for a BRD vaccine. However, the 35-kDa FbpA does 
not appear to be useful as a diagnostic antigen for detection of BRD caused by P. 
haemolvtica. as most calves have been exposed to P. haemolvtica as shown by an 
antibody titer to the purified 35-kDa FbpA. This exposure may occur on the farm, during 
transport, in the order-buyer farm or in the feed lot. 
Interestingly, the deduced amino acid sequence of the FbpA contained potential 
post-translational modification sites for phosphorylation. This raised questions about the 
role of these sites in iron transport across the periplasm into the cytosol that is mediated 
by a permease and an ATPase (Gray-Owen and Schryvers, 1996). 
Future work would include cloning the 35-kDa gene into an expression vector to 
obtain recombinant 35-kDa protein for additional studies to (a) determine iron-binding 
properties, (b) to conduct experimental vaccine studies, (c) to determine how the 35-kDa 
binds to the other proteins involved in iron acquisition, (d) to determine if the protein is 
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